This experience brings interactive coding capabilities building upon existing prompt-based features real-time collaborative partner working alongside you while writing code Amazon Q Developer transforms how you write and maintain code by providing transparent reasoning for its suggestions and giving you the choice between automated modifications or step-by-step confirmation of changes. As a daily user of Amazon Q Developer command line interface (CLI) agent I’ve experienced firsthand how Amazon Q Developer chat interface makes software development a more efficient and intuitive process Having an AI-powered assistant only a q chat away in CLI has streamlined my daily development workflow The new agentic coding experience in Amazon Q Developer in the IDE seamlessly interacts with your local development environment and engage in natural conversations about your code Amazon Q Developer comprehends your codebase context and helps complete complex tasks through natural dialog maintaining your workflow momentum while increasing development speed For existing users, update to the new version. Refer to Using Amazon Q Developer in the IDE for activation instructions To start, I select the Amazon Q icon in my IDE to open the chat interface. For this demonstration, I’ll create a web application that transforms Jupiter notebooks from the Amazon Nova sample repository into interactive applications I send the following prompt: In a new folder create a web application for video and image generation that uses the notebooks from multimodal-generation/workshop-sample as examples to create the applications Adapt the code in the notebooks to interact with models Amazon Q Developer then examines the files: the README file and everything that is in the folder where the conversation is positioned In our case it’s at the root of the repository Amazon Q Developer initiates the application creation process it requests permission to execute the bash command for creating necessary folders and files Amazon Q Developer proceeds to build the complete web application Amazon Q Developer provides the application structure and deployment instructions which can be converted into a README file upon request in the chat During my initial attempt to run the application I described it in Spanish using Amazon Q chat Amazon Q Developer responded in Spanish and gave me the solutions and code modifications in Spanish After implementing the suggested fixes, the application ran successfully. Now I can create, modify, and analyze images and videos using Amazon Nova through this newly created interface The preceding images showcase my application’s output capabilities Because I asked to modify the video generation code in Spanish Things to know Chatting in natural languages – Amazon Q Developer IDE supports many languages, including English, Mandarin, French, German, Italian, Japanese, Spanish, Korean, Hindi, and Portuguese. For detailed information, visit the Amazon Q Developer User Guide page Collaboration and understanding – The system examines your repository structure and documentation while giving you the flexibility to interact seamlessly through natural dialog with your local development environment This deep comprehension allows for more accurate and contextual assistance during development tasks Control and transparency – Amazon Q Developer provides continuous status updates as it works through tasks and lets you choose between automated code modifications or step-by-step review giving you complete control over the development process Availability – Amazon Q Developer interactive agentic coding experience is now available in the IDE for Visual Studio Code Pricing – Amazon Q Developer agentic chat is available in the IDE at no additional cost to both Amazon Q Developer Pro Tier and Amazon Q Developer Free tier users. For detailed pricing information, visit the Amazon Q Developer pricing page To learn more about getting started visit the Amazon Q Developer product web page — Eli How is the News Blog doing? Take this 1 minute survey (This survey is hosted by an external company. AWS handles your information as described in the AWS Privacy Notice AWS will own the data gathered via this survey and will not share the information collected with survey respondents.) My mission is to break down complex concepts into easily digestible explanations inspiring developers to continually expand their skills and knowledge I share my expertise with the global developer community providing them with the tools and confidence to reach their full potential With a hands-on approach and a commitment to simplifying the complex I strive to be a catalyst for growth and learning in the world of AWS technology Drug Delivery Business May 5, 2025 By [Image courtesy of IDE Group]IDE Group recently unveiled OKO its new ophthalmic auto-injector for improving drug delivery precision and efficiency The company says OKO addresses critical unmet needs in ophthalmology procedural efficiency and patient safety compared to existing adapted injection methods intravitreal injections — essential injections for treating retinal diseases like wet age-related macular degeneration and diabetic retinopathy — rely on devices originally intended for entirely different medical applications The mismatch can lead to dosing inaccuracies procedural inefficiencies and risks to patient safety IDE Group developed OKO in collaboration with ophthalmologists in Australia The company says its auto-injector provides up to 59 times greater dosing accuracy compared to prefilled syringes and reduces procedural steps by 45% OKO also significantly enhances patient throughput to cut costs by up to 78% per injection early feedback saw 90% of ophthalmologists say they preferred OKO over conventional prefilled syringes The company is actively preparing its auto-injector for market entry through strategic partnerships and comprehensive clinical validation “IDE’s mission has always been to deliver meaningful innovations to healthcare OKO redefines how ophthalmic drug delivery is implemented by delivering the right drug and improving clinical outcomes,” said Richard Sokolov executive director and co-founder of IDE Group “OKO embodies IDE’s philosophy of combining ambitious innovation with practical experience,” Sokolov added “We are committed to setting a new standard in ophthalmic care enabling pharmaceutical companies and empowering clinicians to preserve their patients’ vision to give them a better quality of life.” Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com Copyright © 2025 · WTWH Media LLC and its licensors The material on this site may not be reproduced except with the prior written permission of WTWH Media Privacy Policy | RSS 30-Day Data from Endospan's NEXUS TRIOMPHE IDE Trial Demonstrate 63% Reduction in Major Adverse Event (MAE) Rate compared with Reference Performance Goal ATLANTA, May 5, 2025 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease today announced the presentation of new clinical data from Endospan's NEXUS TRIOMPHE trial at the 105th American Association for Thoracic Surgery (AATS) Annual Meeting in Seattle The data presented analyzed clinical outcomes across a 54-patient chronic aortic dissection statistical cohort at 30 days following treatment with NEXUS.  Patients enrolled were at high risk for open surgical repair Professor of Surgery and Director of Thoracic Aortic Surgery presented the data from the NEXUS US IDE trial in an abstract titled Endovascular Aortic Arch Repair Using a Novel Single-Branch Arch Stent Graft for Chronic Dissection: 30-Day Outcomes of the TRIOMPHE FDA Pivotal Study The data demonstrate statistically significant improvement in clinical outcomes and device technical performance compared with the performance goals set forth in the FDA-approved investigational device exemption (IDE) or development of new dissections in the thoracic aorta or brachiocephalic artery requiring intervention "The 30-day results from the TRIOMPHE study demonstrate that aneurysms due to chronic aortic arch dissection involving the aortic arch can be successfully treated with this novel off-the-shelf stent graft system.  The NEXUS device provides an excellent minimally invasive alternative to open aortic arch replacement in select patients at high risk for open surgery This novel technology will extend treatment to patients who previously would not be offered therapy due to prohibitive risk" "We are pleased with the 30-day results and look forward to seeing the one-year outcomes," said Pat Mackin President and Chief Executive Officer of Artivion "These results further validate this important therapeutic option for patients with aortic arch disease." About the NEXUS TRIOMPHE Clinical TrialThe NEXUS TRIOMPHE trial is the US IDE study evaluating the NEXUS device in the endovascular treatment of chronic aortic dissection either primary type B or residual dissection after prior type A repair Inclusion criteria include the patient being high risk for open surgical repair The clinical module of the PMA is anticipated to be filed after completion of one year of follow up with the 54 patients in the chronic aortic dissection statistical primary cohort Artivion          Berry                                               [email protected]  a leading cardiac and vascular surgery company focused on aortic disease today announced financial results for the.. Health Care & Hospitals Medical Pharmaceuticals Medical Equipment Clinical Trials & Medical Discoveries Do not sell or share my personal information: Metrics details Prolonged therapy using nucleos(t)ide analogs (NUC) is inevitable in patients with chronic hepatitis B (CHB) infection but its long-term impact on Parkinson’s disease (PD) risk remains unclear This study evaluated the association between NUC therapy and PD incidence in a nationwide CHB cohort The study population comprised the National Health Insurance Service claims database from January 1 only included treatment naïve CHB patients and those without previously diagnosed with PD Participants were followed until PD diagnosis or study completion comparing patients who initiated NUC therapy at cohort entry with those who did not the incidence rate of PD in NUC-treated patients was 1.48 per 1000 persons compared to 1.95 per 1000 persons in the untreated group the 3-year follow-up showed a statistically significant reduction in risk (hazard ratio [HR]: 0.61; 95% confidence interval [CI] 0.39–0.97) In the propensity score-matched cohort of 18,365 pairs the cumulative incidence during 2–4 years of follow-up was significantly lower in the NUC-treated group compared to the untreated group no statistically significant difference in cumulative PD incidence was observed between the groups at the early or late stages of the follow-up period NUC therapy initially reduced PD incidence but this protective effect diminished over time Regular PD screening may be needed for long-term NUC users the impact of NUC therapy on development of ND in patients with CHB has not been studied the use and maintenance of NUC may protect against PD development by suppressing the inflammatory process while long-term NUC use may lead to mitochondrial damage and can be triggered earlier onset of PD we compared the incidence of PD over time in patients with CHB using a national wide claims data from a CHB endemic area to gain insight into whether NUC use is a risk factor or protective factor for PD in terms of therapeutic duration Information on patient demographic characteristics and detailed diagnoses coded with the Korean Standard Classification of Disease Version 5 (modification of the International Statistical Classification of Diseases and Related Health Problems Tenth Revision [ICD-10]) were collected from all individuals a total of 238,219 patients were finally included in this study Patients who were not prescribed NUC at all were classified as the untreated group Patients who were prescribed NUC for CHB and adhered to the treatment regimen for more than 80% of the duration were categorized as the treated group Patients who were treated with NUC and did not meet the adherence rate of 80% were excluded our cohort comprised 18,365 patients who received newly initiated NUC therapy (the treated group) and 212,820 patients who did not receive NUC therapy (the untreated group) and preexisting comorbidities such as diabetes mellitus Participants were followed from the index date until either the diagnosis of PD or the study’s conclusion on December 31 Individuals were censored at the date of death as well as when NUC therapy was discontinued in the treatment group or newly initiated in the untreated group This study was approved by the Institutional Review Board of Hanyang University Guri Hospital (IRB No with all methods conducted in accordance with relevant guidelines and the Declaration of Helsinki Written informed consent was waived due to the retrospective design The primary outcome of this study was the incidence of PD during the follow-up period only those whose PD occurred more than 6 months after cohort entry were analyzed We defined newly diagnosed cases of PD as individuals who were newly diagnosed with and if there were several claims with PD codes (G20) the first instance it occurred was considered the time of PD diagnosis The secondary outcome was to identify the risk factors associated with PD in patients with CHB infection with or without NUC therapy Propensity score (PS)- matching analysis was performed to reduce the effect of selection bias and potential confounding factors between the treated and non-treated groups Propensity scores were derived using the following variables: age “%OneToManyMTCH,” was used for this caliper matching of nearest-neighbor approach for the first four to eight digits of propensity scores and p values < 0.05 were considered statistically significant Comparison of the incidence rates of Parkinson disease between the NUC-treated and untreated groups using (A) Kaplan–Meier analysis and (B) an estimate of the hazard function ratio (with pointwise bands showing 95% confidence intervals) Despite the widespread use of NUCs globally there has been no research investigating the impact of NUCs on PD incidence we focused on NUC treatment-naïve patients at the time of cohort entry to compare the risk of PD development between those who initiated and maintained NUC therapy and those who did not We aimed to explore the relationship between NUC use and PD incidence as well as any hidden clinical phenotypes associated with the mechanism Our study found that PD incidence decreased in the years following NUC initiation These findings suggest that the duration of NUC therapy may have time-varying clinical impact on PD development in CHB patients offering early protection but potential toxicity with long-term use the time-varying effect of NUC therapy was also observed in subgroups suggesting that the changes in PD incidence over time may be related more to the effect of NUC treatment itself rather than specific subgroups Whether the time-varying effects of NUC therapy on PD incidence are observed across different subgroups remains to be elucidated If the effects of NUCs on PD risk are time-varying previous research may have failed to fully capture the relationship between CHB and PD incidence Further research is needed to elucidate the underlying mechanisms behind the time-varying effects of NUC use on PD risk While the retrospective observational design of this study introduces inherent limitations we mitigated these by leveraging a nationally representative dataset from a CHB-endemic region We employed stringent exclusion criteria to accurately evaluate the potential impact of NUC therapy on PD incidence in CHB patients we used propensity score matching and incorporated competing risk analysis to enhance the robustness of our findings Another limitation is the inability to account for variables not included in the claims data such as known PD risk factors or the effects of medications other than NUCs including baseline and serial laboratory data related to viral status on the association between NUC use and PD incidence remains uncertain it remains unclear how PD incidence might be influenced by NUC use or non-use outside of insurance coverage or due to individual clinical decisions we were unable to fully elucidate the underlying mechanisms and it remains unclear whether other neurodegenerative diseases that share mitochondrial damage as a common mechanism exhibit similar incidence patterns or the type of NUC used were also not explored Although these factors may have had differential effects on PD incidence they could not be separately analyzed in this study our study is the first to investigate the various mechanisms of PD development including neuroinflammation from chronic liver inflammation and mitochondrial damage caused by long-term NUC therapy initiating NUC therapy initially provided a protective effect against PD incidence; however suggesting a clinically relevant time-varying impact possibly related to the long-term toxicity of NUCs Given the necessity of long-term NUC therapy for CHB management there may be a need for PD screening in long-term NUC users Further studies are needed to replicate these findings and confirm their validity Data used in this study are maintained by the Korea National Health Insurance Service (NHIS, https://nhiss.nhis.or.kr) and available from corresponding author upon submitting a proposal to be approved by the NHIS Global, regional, and national burden of hepatitis B, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterol. Hepatol. 7, 796–829. https://doi.org/10.1016/S2468-1253(22)00124-8 (2022) Huang, D. Q. et al. Global epidemiology of cirrhosis: Aetiology, trends and predictions. Nat. Rev. Gastroenterol. Hepatol. 20, 388–398. https://doi.org/10.1038/s41575-023-00759-2 (2023) Korean Association for the Study of the, L. KASL clinical practice guidelines for management of chronic hepatitis B. Clin. Mol. Hepatol. 28, 276–331. https://doi.org/10.3350/cmh.2022.0084 (2022) Terrault, N. A. et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology 67, 1560–1599. https://doi.org/10.1002/hep.29800 (2018) Lampertico, P. et al. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J. Hepatol. 67(2), 370–398. https://doi.org/10.1016/j.jhep.2017.03.021 (2017) Hsu, Y. C., Tseng, C. H. & Kao, J. H. Safety considerations for withdrawal of nucleos(t)ide analogues in patients with chronic hepatitis B: First, do no harm. Clin. Mol. Hepatol. 29, 869–890. https://doi.org/10.3350/cmh.2022.0420 (2023) Liem, K. S., Gehring, A. J., Feld, J. J. & Janssen, H. L. A. Challenges With stopping long-term nucleos(t)ide analogue therapy in patients with chronic hepatitis B. Gastroenterology 158, 1185–1190. https://doi.org/10.1053/j.gastro.2019.10.050 (2020) Roade, L., Riveiro-Barciela, M., Esteban, R. & Buti, M. Long-term efficacy and safety of nucleos(t)ides analogues in patients with chronic hepatitis B. Ther. Adv. Infect. Dis. 8, 2049936120985954. https://doi.org/10.1177/2049936120985954 (2021) de Fraga, R. S., Van Vaisberg, V., Mendes, L. C. A., Carrilho, F. J. & Ono, S. K. Adverse events of nucleos(t)ide analogues for chronic hepatitis B: A systematic review. J. Gastroenterol. 55, 496–514. https://doi.org/10.1007/s00535-020-01680-0 (2020) Fontana, R. J. Side effects of long-term oral antiviral therapy for hepatitis B. Hepatology 49, S185-195. https://doi.org/10.1002/hep.22885 (2009) Fleischer, R. D. & Lok, A. S. Myopathy and neuropathy associated with nucleos(t)ide analog therapy for hepatitis B. J. Hepatol. 51, 787–791. https://doi.org/10.1016/j.jhep.2009.06.011 (2009) Madeddu, G. et al. Mitochondrial toxicity and body shape changes during nucleos(t)ide analogues administration in patients with chronic hepatitis B. Sci. Rep. 10, 2014. https://doi.org/10.1038/s41598-020-58837-3 (2020) Feng, J. Y. Addressing the selectivity and toxicity of antiviral nucleosides. Antivir. Chem. Chemother. 26, 2040206618758524. https://doi.org/10.1177/2040206618758524 (2018) Lin, M. T. & Beal, M. F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443, 787–795. https://doi.org/10.1038/nature05292 (2006) Bose, A. & Beal, M. F. Mitochondrial dysfunction in Parkinson’s disease. J. Neurochem. 139(Suppl 1), 216–231. https://doi.org/10.1111/jnc.13731 (2016) Ben-Shlomo, Y. et al. The epidemiology of Parkinson’s disease. Lancet 403, 283–292. https://doi.org/10.1016/S0140-6736(23)01419-8 (2024) Viral hepatitis and Parkinson disease: A national record-linkage study Lin, W. Y. et al. Association of antiviral therapy with risk of Parkinson disease in patients with chronic hepatitis C virus Infection. JAMA Neurol. 76, 1019–1027. https://doi.org/10.1001/jamaneurol.2019.1368 (2019) Kyoung, D. S. & Kim, H. S. Understanding and utilizing claim data from the Korean National Health Insurance Service (NHIS) and health insurance review & assessment (HIRA) database for research. J. Lipid Atheroscler. 11, 103–110. https://doi.org/10.12997/jla.2022.11.2.103 (2022) Lim, J., Kim, Y. J., Kim, S. & Choi, J. Increased risk of osteoporotic fracture in patients with autoimmune hepatitis. Am. J. Gastroenterol. https://doi.org/10.14309/ajg.0000000000002354 (2023) Jo, S. et al. Association of NO2 and other air pollution exposures with the risk of Parkinson disease. JAMA Neurol. 78, 800–808. https://doi.org/10.1001/jamaneurol.2021.1335 (2021) Park, J. H. et al. Trends in the incidence and prevalence of Parkinson’s disease in Korea: A nationwide, population-based study. BMC Geriatr. 19, 320. https://doi.org/10.1186/s12877-019-1332-7 (2019) Fine, J. P. & Gray, R. J. A proportional hazards model for the subdistribution of a competing risk. J. Am. Stat. Assoc. 94, 496–509. https://doi.org/10.1080/01621459.1999.10474144 (1999) Kim, G. A. et al. Association between non-alcoholic fatty liver disease and the risk of dementia: A nationwide cohort study. Liver Int. 42, 1027–1036. https://doi.org/10.1111/liv.15244 (2022) Wileyto, E. P., Li, Y., Chen, J. & Heitjan, D. F. Assessing the fit of parametric cure models. Biostatistics 14, 340–350. https://doi.org/10.1093/biostatistics/kxs043 (2013) Uno, H. et al. Moving beyond the hazard ratio in quantifying the between-group difference in survival analysis. J. Clin. Oncol. 32, 2380–2385. https://doi.org/10.1200/JCO.2014.55.2208 (2014) Huang, Q. & Tian, C. Visualizing time-varying effect in survival analysis: 5 complementary plots to Kaplan–Meier curve. Oxid Med Cell Longev 2022, 3934901. https://doi.org/10.1155/2022/3934901 (2022) Felipo, V., Montoliu, C. & Llansola, M. Neuroinflammation and neurological alterations in chronic liver diseases. Neuroimmunol. Neuroinflammation https://doi.org/10.4103/2347-8659.160845 (2015) Morris, H. R., Spillantini, M. G., Sue, C. M. & Williams-Gray, C. H. The pathogenesis of Parkinson’s disease. Lancet 403, 293–304. https://doi.org/10.1016/S0140-6736(23)01478-2 (2024) Apetauerova, D. et al. A prospective study of the prevalence of parkinsonism in patients with liver cirrhosis. Hepatol. Commun. 5, 323–333. https://doi.org/10.1002/hep4.1624 (2021) Choi, H. Y., Mai, T. H., Kim, K. A., Cho, H. & Ki, M. Association between viral hepatitis infection and Parkinson’s disease: A population-based prospective study. J. Viral Hepat. 27, 1171–1178. https://doi.org/10.1111/jvh.13346 (2020) Goldstein, L., Fogel-Grinvald, H. & Steiner, I. Hepatitis B and C virus infection as a risk factor for Parkinson’s disease in Israel-A nationwide cohort study. J. Neurol. Sci. 398, 138–141. https://doi.org/10.1016/j.jns.2019.01.012 (2019) Golabi, P. et al. The prevalence of Parkinson disease among patients with hepatitis C infection. Ann. Hepatol. 16, 342–348. https://doi.org/10.5604/01.3001.0009.8588 (2017) Wu, W. Y. et al. Hepatitis C virus infection: A risk factor for Parkinson’s disease. J. Viral Hepat. 22, 784–791. https://doi.org/10.1111/jvh.12392 (2015) Yaow, C. Y. L. et al. Risk of Parkinson’s disease in hepatitis B and C populations: A systematic review and meta-analysis. J. Neural Transm. (Vienna) https://doi.org/10.1007/s00702-023-02705-7 (2023) Zhang, Y. et al. Long-term exposure of mice to nucleoside analogues disrupts mitochondrial DNA maintenance in cortical neurons. PLoS ONE 9, e85637. https://doi.org/10.1371/journal.pone.0085637 (2014) Download references This study was supported by The Research Supporting Program of the Korean Association for the Study of the Liver (KASL2023-04) and by the Research fund of Hanyang University (HY-202500000001286) Hyo Young Lee and Hyunji Sang contributed equally to this work and share first authorship Division of Gastroenterology and Hepatology Department of Endocrinology and Metabolism Department of Gastroenterology and Hepatology and HIK were involved in the study concept and design All authors were responsible for the data acquisition and critical revision of the manuscript and approved the final version and HS contributed equally to this work and share first authorship The authors declare no competing interests Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations Below is the link to the electronic supplementary material Download citation DOI: https://doi.org/10.1038/s41598-025-00110-6 Anyone you share the following link with will be able to read this content: a shareable link is not currently available for this article Sign up for the Nature Briefing newsletter — what matters in science AWS has added Model Context Protocol (MCP) support to its Q Developer AI-driven coding assistant initially only for the command line (CLI) but with support within IDEs (via the Q Developer plugin) promised “in the coming weeks.” MCP is an API introduced by Anthropic to standardize how AI assistants and agents communicate with tools, giving the AI important new capabilities but also introducing new risks AWS is putting the emphasis on MCP as a source of context and data for AI rather than to empower agentic AI MCP servers for Q Developer can be configured globally or just for the current workspace using JSON files which describe how to start the server and environment variables such as secrets giving access to services tools can be invoked either with natural language Regarding security, the documentation states that MCP support is designed to require specific user permission and isolation with each MCP server in a separate process most of the security burden falls on the user with a plea to only install MCP servers from trusted sources and to examine them carefully to keep MCP servers up to date with the latest versions and to monitor logs for “unexpected activity.” Many worry about MCP risks. Security outfit Wiz said in a post that “MCP introduces a broad range of security risks.” However vendors appear to worry more about being left behind as their competitors add MCP support Google and many others have added both support in their AI offerings and servers enabling access to their services DevClass is the news and analysis site covering modern software development issues from the team behind the Continuous Lifecycle Serverless Computing and MCubed conferences Contact us: devclass@sitpub.com Let’s be real: The debate over whether hardware designers and verification engineers need an integrated development environment (IDE) isn’t just a passing trend—it’s an ongoing conversation while others can’t imagine working without the bells and whistles of a modern IDE An IDE is like a Swiss Army knife for developers—it’s a toolbox wrapped in a sleek GUI that combines a source code editor and even integration with version control systems like Git It’s not just for software developers; it’s for anyone who writes code—yes let’s bust some myths and show you why an HDL-focused IDE is a must-have for your workflow Reality: IDEs are for anyone who writes code Sure, software developers swear by their IDEs. Let’s not forget that hardware description languages (HDLs) such as SystemVerilog and VHDL are still code You’re not just describing hardware; you’re writing instructions that manipulate registers and logic Why should software developers have all the fun Reality: Even experts need tools to stay sharp You know the Language Reference Manual (LRM) like it's your favorite novel Let’s be honest: With chips packing over 280 billion transistors and new standards popping up faster than you can say “Moore’s Law,” even experts need a little help An IDE isn’t a crutch—it’s a force multiplier It lets you focus on the hard stuff (like designing killer logic) while it handles the mundane (like syntax errors and project management) while experts use it to find the fastest route Whether you're new to the road or a seasoned driver and documentation aren’t just for newbies—they’re for anyone who wants to write better code faster Even the most seasoned pros appreciate a little help staying on track The truth is that the best way to learn is by making mistakes If you’re flagged every time you mess up you’ll stop making that mistake sooner you might not even realize your error until you’re knee-deep in simulation logs and by then Reality: Modern IDEs are lightweight and fast and so nimble that they’ll make your old editor look like it's running in slow motion 74% of developers in the 2024 Stack Overflow survey named VS Code as their go-to IDE runs everywhere—and with the Remote Secure Shell (SSH) protocol you can even use it to work on remote servers Your graphics are handled on your local machine and the heavy lifting happens wherever you have it Reality: IDEs shine on projects of any size Even a seemingly simple design can contain common errors let’s look at a straightforward VHDL code example: Looks harmless, right? Try writing this with Sigasi Visual HDL (SVH) for example—it’ll catch mistakes you didn’t even know you were making It will synchronize the state-machine diagram with your code as you type it in: The IDE platform will flag you back quite a few times It doesn't just help you write code; it spotlights your mistakes before they become headaches How many problems do you find in this "small" piece of code High-quality IDE plugins may come with a price but they quickly pay for themselves by saving you valuable time a good plugin can shave hours off of your workflow the tools pay for themselves in just a few weeks the savings add up to millions of dollars over the years and Notepad++ are great for basic code editing but they fall short when compared to the power and flexibility of a true IDE Features like Source Code Management integration and Automatic Code-Driven Documentation are game-changers—turning your IDE into a full-fledged HDL platform Reality: Artificial intelligence is a tool but it's not about to write your entire design for you but you’re still the one in the driver’s seat A modern IDE is the perfect platform to integrate AI tools while keeping you in control The creativity of AI must be guided by the deterministic behavior of an IDE’s language server Think of it as a creative assistant with guardrails—innovative The combination of AI with an IDE will make you thrive even more kept from hallucinating through the guardrails of coding semantics Reality: IDEs do way more than just code editing An IDE isn't just a fancy text editor—it's a project management powerhouse with a side of code-editing magic From version control to debugging to documentation It creates order in the chaos of your source files A search for a file somewhere on the network becomes a simple navigation for declarations and implementations ensuring your code stays clean and consistent IDEs aren’t just for software developers including hardware designers and verification engineers Why stick to a text editor when you can have a full-fledged HDL platform at your fingertips It's time to embrace the future of hardware design and leave the headaches of the past behind Sigasi’s Vice President of Business Development combines his EDA career with creating bleeding-edge ASICs and FPGAs he’s responsible for expanding the global market presence of its EDA tools that enable FPGA and ASIC designers to work more efficiently and effectively with modern software development methodologies and languages Please select what you would like included for printing: Copy the text below and then paste that into your favorite email application Robert graduated from Hamden High and SCSC He loved going to Disney World with his grandchildren whenever they visited in Florida He served in the US Army and was stationed in Viet Nam for three years Amanda (Patrick) Hunt and five adoring grandchildren – Aiden He was predeceased by his parents and a brother Memorial contributions may be made to The Cholangiocarcinoma Foundation Family and friends are invited to pay their respects on Saturday 2024 from 9:30 AM to 11:15 AM at the Alderson-Ford Funeral Home A Mass of Christian Burial will be celebrated at 12:00 noon A Graveside Service with Military Honors will follow at St Enter your phone number above to have directions sent via text This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply Service map data © OpenStreetMap contributors Events This comprehensive workshop will provide you with in-depth guidance on the latest FDA regulations impacting the submission process and will help medtech professionals understand what’s needed for approval on their new technologies. This knowledge can expedite the journey to clinical trials and eventually to market, giving companies a competitive advantage. The IDE Workshop offers hands-on learning through case studies, interactive discussions, and practical exercises, guiding attendees through the IDE submission process. We’re excited to offer a hybrid format that creates a comprehensive and interactive experience, while providing exclusive access to leading industry professionals for those attending in our Washington, D.C. office. These workshops are valuable for anyone aiming to streamline the regulatory process, reduce submission risks, and confidently bring their device to market such as: Tony Blank, Senior Director of Regulatory Affairs, AtriCure  Blank has been an active representative for the medical device industry and the regulatory profession on numerous policy issues working with AdvaMed®. Among these activities has been participation in numerous Industry Working Groups including the Pediatric Devices, Advertising and Promotion, and Reprocessing Working Groups (each of which he co-chaired).  Blake Wilson, Partner, Global Regulatory, Hogan Lovells  Blake Wilson helps medical device, drug, and biologic companies successfully navigate FDA’s evolving regulatory landscape. With a focus on premarket submissions and clinical trial design and conduct, Blake helps sponsors plan their product development strategy and minimize regulatory risks.   Gain strategies for assembling and streamlining effective 510(k) and De Novo submissions and obtain insight into the 510(k) and De Novo review process during this interactive two-day workshop. This workshop will cover: Using real-world case studies, this workshop will walk you through the practical steps of filing a PMA and offer you actionable insights on how to best navigate the PMA submission process. steps required, best practices and preparation for inspection will be covered throughout this workshop. This workshop will cover: Washington, D.C.—AdvaMed, the Medtech Association, today released its “AI Policy Roadmap,” a detailed policy outline for Congress and the federal agencies with jurisdiction over medtech to consider in promoting the next era of artificial intelligence-enabled medical and digital health technologies to provide patients and clinicians transformative new tools to aid in diagnosis and treatment.  Washington, D.C.– AdvaMed®, the Medtech Association, today released the following statement from President and CEO Scott Whitaker on the U.S. Senate’s confirmation of Dr. Mehmet Oz to serve as Administrator of the U.S. Centers for Medicare and Medicaid Services.   This in-depth 510(k) & De Novo Guidebook will provide real-world case studies, tips and best practices directly from FDA and industry experts. AdvaMed®’s medtech priorities for the 119th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today. Download Sedgwick’s Global Medical Device Recall Report for key insights on compliance, regulations, and global recall trends. Members only. Sidley Austin, joined by HPA, will lead a program examining the impact of HHS repealing the so-called “Richardson Waiver”, including its history, how it could impact the activities of the U.S. Department of Health and Humans Services (HHS), what it all means for medtech and its patients. Washington, D.C.– AdvaMed®, the Medtech Association, today released the following statement from President and CEO Scott Whitaker on the U.S. Senate’s confirmation of Dr. Marty Makary to serve as commissioner of the U.S. Food and Drug Administration.  Sign up to receive emails highlighting our upcoming events, early registration savings, and engagement opportunities for the medical technology community. Speeding Up Merck’s Process from 6 Months to 6 Hours with an AI R&D Assistant 60% More Engagement With Hyper-Personalization for a US Proptech A Step by Step Guide to De-Risking Product Globalization Mastering Product Information Management: Your Key to the Digital Age Kacper Rafalski Looking for the best Ruby IDE to enhance your productivity This article breaks down the top Ruby IDEs and text editors we’ll help you find the right IDE for your needs Integrated Development Environments (IDEs) for Ruby streamline coding enabling developers to build robust Ruby applications efficiently These tools offer a unified environment that integrates essential features significantly boosting productivity and ensuring a smooth workflow The choice of Ruby IDE can greatly affect the software development life cycle, enhancing standardization, speed, and code quality. Beyond convenience, the appropriate IDE aligns with business needs and streamlines the software development process Recognizing key IDE features helps in making informed decisions A Ruby on Rails IDE’s main function is to enhance coding efficiency Understanding what an IDE is and the benefits of using one for Ruby development is crucial An Integrated Development Environment (IDE) is a full-featured programming tool that merges a text editor with advanced functionalities like code auto-completion and build automation—allow developers to write IDEs come with specialized features like syntax highlighting which improve code navigation and development efficiency IDEs like RubyMine offer syntax highlighting and autocompletion to streamline the coding process An IDE for Ruby development offers several benefits that enhance productivity, such as code completion includes database management tools and version control systems These features streamline the development process and minimize time on routine tasks, allowing developers to concentrate on writing quality code. This combination of tools makes IDEs essential for Ruby developers, whether working on small scripts or large-scale Rails web development applications Several IDEs stand out in Ruby development for their robust features and user-friendly environments. Popular choices include RubyMine, Visual Studio Code, Atom Editor, and Sublime Text. Each offers unique features catering to different aspects of Ruby development, integrating essential tools for coding Whether seeking advanced editing capabilities RubyMine is considered the best commercial IDE for Ruby Though subscription-based and sometimes seen as heavy on performance RubyMine is trusted globally for its comprehensive features Its capability to handle complex Rails projects makes it a preferred choice for Ruby developers popular among developers with a 73.71% usage rate as of 2023 It boasts a lightweight yet powerful architecture and integrates well with Git for version control the vscode-ruby extension offers IntelliSense VS Code’s extensibility allows developers to customize their development environment to fit their specific needs making it a versatile choice for Ruby development It provides essential features like syntax highlighting Atom also supports Ruby development with plugins such as linter-ruby While Atom may not be as feature-rich out of the box compared to other IDEs additional packages can enhance its functionality Its multi-platform support and customizability make it a flexible tool for Ruby development known for its lightweight nature and speed Although it lacks the built-in features of full-fledged IDEs its performance and ease of use make it a favorite among developers who prefer a minimalist approach Free Ruby IDE offers an efficient way for developers to work without licensing fees These tools enhance productivity with features like code suggestions provides a range of customizable features for Ruby development We’ll now explore some of the best free Ruby IDEs These tools cater to various development needs and preferences making them valuable assets for Ruby developers Cloud9 is a cloud-based IDE enabling real-time collaboration ideal for developing serverless applications One of Cloud9’s key advantages is its accessibility from any location on any device making it attractive for developers seeking flexibility NetBeans is a widely-used open-source IDE for Ruby on Rails framework and is a popular choice among developers It offers prioritized code completion suggestions and smart hints to help with code mistakes Geany is a lightweight and fast IDE supporting multiple programming languages Developers can enhance Ruby's programming capabilities with the enhanced-ruby-mode plugin Geany offers essential features for Ruby scripting Specialized text editors are vital for Ruby development offering unique features that boost programming efficiency Customization options enable developers to tailor their editors to fit individual workflows and preferences We will now explore some of these specialized text editors VIM is highly regarded among Ruby on Rails developers for its speed, keyboard shortcuts, and extensive plugin support. It is particularly well-suited for Linux and performs comparably to modern IDEs. Plugins like vim-ruby and vim-rails significantly enhance Ruby on Rails development A key benefit of VIM is the ability to code quickly using only the keyboard Engineers at companies like Facebook use VIM highlighting its efficiency and reliability allowing users to tailor the environment extensively It functions as both a text editor and an IDE making it highly adaptable for various programming tasks make it a powerful tool for Ruby developers seeking a customizable and efficient coding environment Choosing the right IDE for Ruby development involves considering several factors that can significantly impact productivity and coding experience Select an IDE that aligns with your project requirements Evaluating these aspects helps find an IDE that meets your current needs and supports your growth as a developer Ensuring IDE compatibility with the operating systems used by your team is crucial for a smooth workflow or Linux ensures all team members can work efficiently without platform-specific issues An intuitive IDE with clear documentation can reduce the time developers spend learning to use it Customizing shortcuts and personalizing setups makes the coding process more comfortable and efficient An IDE should seamlessly integrate with tools like testing frameworks and version control systems to maximize productivity Plugins can enhance Ruby Rails ide functionality by adding features like syntax highlighting Many Ruby IDEs integrate terminal functionality streamlining workflows by allowing developers to execute commands without leaving the environment This seamless integration is essential for maintaining an efficient development process When considering IDEs for Ruby development compare free options with paid alternatives and evaluate if the features of a paid IDE justify the cost RubyMine costs $229 annually per user after the trial period but includes significant updates and support allowing free use with an option to donate A strong community around an IDE provides invaluable resources and support Community support aids in troubleshooting and ongoing learning crucial for Ruby developers seeking to improve their skills IDEs like NetBeans and Aptana benefit from active communities Ruby IDEs enhance developer productivity by reducing setup time and build automation streamline the development workflow This section will explore how to maximize the use of your Ruby IDE through plugins and extensions and customizing your IDE to fit your specific needs Plugins and extensions can significantly enhance IDE functionality by adding features like context-aware AI chat which assists users in receiving instant information about their code Emacs is highly customizable for Ruby development allowing developers to enhance their experience with various plugins like Rake creating a user-friendly coding environment that requires minimal configuration Customizing your IDE with plugins and extensions can lead to improved productivity RubyMine offers debugging capabilities including improved code insights enhancing the development experience through its debugger interface Integrated project management tools in IDEs like Emacs allow developers to manage their development timelines and tasks efficiently Built-in tools like debuggers and project management features are essential for improving productivity in Ruby development Customizing your IDE allows you to tailor the development environment to your specific workflow needs An Integrated Development Environment (IDE) typically includes features like a code editor Tailoring your IDE can lead to enhanced productivity through faster coding allowing you to focus on solving coding problems rather than dealing with the environment Choosing the right Ruby IDE or text editor can transform your development experience significantly boosting productivity and efficiency From comprehensive IDEs like RubyMine and Visual Studio Code to specialized text editors like VIM and Emacs each tool offers unique features that cater to different aspects of Ruby development and community support when selecting your IDE Enhancing your productivity further involves leveraging plugins and extensions the best Ruby IDE or text editor is one that aligns with your workflow and project requirements helping you deliver high-quality code efficiently The primary benefits of using an IDE for Ruby development include enhanced productivity through features like code completion Visual Studio Code is indeed suitable for Ruby development particularly when utilizing the vscode-ruby extension This makes it an effective tool for Ruby developers RubyMine is a preferred choice among developers due to its intelligent code completion, advanced debugging features, and robust refactoring tools, which enhance productivity for Ruby and Rails projects several free IDEs are available for Ruby development which provide various features to enhance your coding experience To enhance your productivity with Ruby IDEs take advantage of built-in tools like debuggers and project management features and customize your IDE to align with your workflow usable products with blazing-fast efficiency Let's talk business DevOps.com Eclipse Foundation to Release Open Source IDE Infused with AI Agents By: on March 13 The Eclipse Foundation today made available an alpha release of an instance of its open source Theia integrated development environment (IDE) that provides access to artificial intelligence (AI) agents that will automate a wide range of coding tasks on behalf of application developers the consortium is making generally available the framework that IDE is built on to any organization that wants to build its own AI-infused IDE Contributed to the consortium by EclipseSource a provider of a framework for building IDEs the AI-Powered Theia IDE provides access to coding agents that application developers can expose to any large language model (LLM) they prefer The edition of the Theia IDE promises to make it possible for application developers to be able to orchestrate the entire prompt engineering flow and determine which data and knowledge sources are used as they continuously fine-tune interactions with LLMs including creating interactive chat interfaces or crafting fully customized user interface (UI) elements executive director of the Eclipse Foundation said that approach prevents organizations from having to worry about becoming locked into proprietary LLMs at a time when the pace of generative AI innovation is only going to continue to accelerate Application developers will be able to invoke agents capable of mix and match LLMs based on the current capabilities provided rather than always being dependent on how advanced a specific LLM might be at any given time a Model Contextual Protocol (MCP)makes it possible to connect AI-driven workflows with external tools services and other data sources to facilitate interoperability Integration with SCANOSS tools will also enable developers to analyze the code they create using AI tools to ensure it complies with open-source licensing policies Once the AI-Powered Theia IDE becomes generally available the AI coding equation will be fundamentally changed In addition to greatly expanding the number of IDEs with AI capabilities that might be made available by multiple vendors some DevOps teams might opt to build their own IDE based on open-source code There will be little reason to rely on proprietary IDEs most of which are forks of the open source VS Code IDE The Theia IDE being built by the Eclipse Foundation is yet another example of how the open source community is quickly closing an AI gap with providers History is a guide that over time the pace of innovation occurring in the open-source community will soon surpass the ability of any one vendor to keep pace The challenge and the opportunity now is to foster the next wave of application development by getting AI coding tools into the hands of as many application developers as possible at the lowest cost possible the onus will be on providers of LLMs to keep pace with the needs of those developers versus always forcing them to be dependent on the capabilities a single vendor decides when to make available April 16, 2025 | April 10, 2025 | March 7, 2025 | February 25, 2025 | February 19, 2025 | © 2025 ·Techstrong Group, Inc.All rights reserved DC—The ACURATE investigational device exemption (IDE) trial has provided disappointing results with the Acurate neo2 TAVI valve (Boston Scientific) falling short of noninferiority versus commercially available devices among patients with symptomatic severe aortic stenosis across the spectrum of operative risk or rehospitalization was 16.16% in patients treated with Acurate neo2 and 9.53% among those treated with valves from the Evolut (Medtronic) or Sapien (Edwards Lifesciences) platforms The difference did not meet criteria for noninferiority with an 8% margin MD (Houston Methodist DeBakey Heart & Vascular Center Reardon offered a range of theories as to why the trial did not deliver the hoped-for results including the impact of the COVID pandemic on enrollment nearly 3 months between Acurate neo2 implants and most operators (72%) did five or fewer cases over the course of the study “That led to kind of an unfamiliarity with the valve,” Reardon told TCTMD A post-hoc review of cases found that underexpansion of the valve frame—something that could be corrected easily if identified during the procedure—occurred in about 20% of Acurate neo2 implants “Valve underexpansion is something that the whole field is starting to recognize now as a real problem for long-term valve outcomes,” he said noting that in analyses with only well-expanded valves outcomes were much more similar between trial arms It remains to be seen whether these additional analyses will be enough to convince the US Food and Drug Administration that the Acurate neo2 which is already available in Europe and elsewhere is safe and effective and should be approved I suspect they won’t approve the valve a priori,” Reardon said “My hope is that they’ll recognize that this is an identifiable problem that has a very reasonable and then let us provide some further testing that shows them that if we do the things we need to do to assure full expansion then we get results that are going to be equivalent to what the valves on the market [provide] today.” Speaking with TCTMD, Jan-Malte Sinning, MD (Cellitinnen-Krankenhaus St. Vinzenz, Cologne, Germany), said that in his TAVI practice he uses about 50% Sapien valves, 40% Evolut valves, and 10% Acurate neo2 valves, adding that he was “a little bit surprised” by the findings of ACURATE IDE in light of the promising results from prior registries The main takeaway from the ACURATE IDE trial is that “the overall performance of the Acurate neo2 is not bad it’s not exactly the same standard of care that Evolut FX or Sapien 3 Ultra provides us with At least it seems like it’s not a valve platform for all-comers the Acurate neo2 is “an alternative—not less I wouldn’t say it’s a real competitor for transcatheter heart valves such as the Evolut FX and the Sapien 3.” conducted at 70 centers in the United States and Canada is the first TAVI trial that includes all four levels of operative risk—low Investigators enrolled 1,500 patients (mean age about 79 years; 52% women) who had symptomatic severe aortic stenosis had a documented aortic annulus size of 21 to 27 mm They were randomized to receive the Acurate neo2 or commercially available balloon-expandable Sapien valves (Sapien 3 and Sapien 3 Ultra) or self-expanding Evolut valves (CoreValve Evolut R Evolut FX); about two-thirds received a Sapien valve and about one-third an Evolut valve Roughly a quarter (27%) of patients had high/extreme operative risk Procedural characteristics were largely similar in the Acurate neo2 and control arms although the former had more frequent predilation during the index procedure (99.6% vs 33.0%) and postdilation balloon use (26.1% vs 11.3%; P < 0.001 for both) with a recommended balloon size 1-mm smaller than the annular diameter The primary endpoint of the trial was the composite of all-cause mortality or rehospitalization for valve-related symptoms or worsening congestive heart failure assessed using a Bayesian analysis at 1 year The posterior median difference between the Acurate neo2 and control arms was 6.63% (95% BCI 3.04%-10.20%) with the upper bound of the confidence interval exceeding the 8% noninferiority margin A Kaplan-Meier analysis showed a significantly higher 1-year rate of the primary endpoint (by 5.8%; 95% CI 2.4%-9.1%) Each component was at least numerically higher in the Acurate neo2 arm—death (5.0% vs 3.9%) and rehospitalization (5.3% vs 3.5%)—although only the difference in stroke was statistically significant Patients treated with Acurate neo2 versus commercial valves also had higher rates of CV death (3.7% vs 1.8%) and MI (2.4% vs 0.7%) with the latter finding driven by spontaneous events occurring more than 72 hours after the implant “so it’s not something related to the procedure,” Reardon said Echocardiographic outcomes showed Acurate neo2 provided mean gradients similar to those seen with Evolut valves and lower than those seen with Sapien valves as well as Doppler velocity index values that were comparable to self-expanding valves and better than the balloon-expandable valves none/trace paravalvular regurgitation (PVR) was present in 75.9% of Acurate neo2-treated patients and 93.3% of those treated with Sapien valves there was an unusual increase in mild PVR across all three groups “This is not something we see in our trials It’s not something I see in a pretty extensive clinical practice So there’s some anomaly here that deserves a little more study which we’re doing right now,” he said at a press conference the investigators dug into what might have gone wrong for Acurate neo2 It did not appear to be related to difficulty in implanting the device “The procedural outcomes for both arms were excellent The lack of experience did not affect the implant and it only separated out between 30 days and 1 year,” Reardon said echo parameters were as expected and there were no acute safety signals A case review identified underexpansion of the Acurate neo2 in roughly one-fifth of cases Additional bench testing showed that fully expanded valves had low-velocity whereas underexpanded valves had higher-velocity “and even a kink in the belly of the leaflet,” Reardon said this is a very plausible reason for platelet activation Those are the kind of things that can explain the myocardial infarctions after 72 hours and can be related to stroke.” Further post-hoc analyses showed that underexpanded versus fully expanded valves had at least numerically higher 1-year rates of death or hospitalization (18.8% vs 12.4%; P = 0.050) and a nonsignificantly lower rate of rehospitalization (2.7% vs 5.9%; P = 0.131) fully expanded Acurate neo2 valves had similar rates of adverse clinical outcomes through 1 year “showing that if we really could expand these valves we should really get a very good result,” Reardon said He said addressing underexpansion should be relatively straightforward noting that operators didn’t know how to look for the issue when the procedures were being done and also often used smaller-than-recommended balloons for pre- and postdilation Underexpanded valves can be seen on imaging using the right anterior oblique view as the commissural posts not being parallel and the waist of the valve not being as wide as the valve height then we would hopefully see results that look much more like the control results,” Reardon told TCTMD “That’s an educational thing that I think we need to take forward as we create a checklist of things—here’s what you need to see.” Reardon suggested that despite the missed primary endpoint in ACURATE IDE noting that it has some unique characteristics which stabilizes [it] and allows you to accurately deploy a short-frame And what this does is gives you some things that are like the balloon-expandable valve—rapid and a low pacemaker [rate],” he explained to the media “And yet it has the superior hemodynamics of a self-expanding valve and commissural alignment.” Reardon told TCTMD “it would be a travesty to not have an opportunity to bring this valve to the US market because having used it Sinning agreed that the Acurate neo2 has some positive attributes including the combination of the features of a self-expanding valve which is “less aggressive” than a balloon-expandable valve and improved access to the coronary arteries this platform might perform worse in heavily calcified annuli,” he added observed that while the ease of coronary access is a plus with Accurate neo2 currently available valves “have a very high standard and to actually get there and displace them the new valve has to be equal or even better a member of the American College of Cardiology’s interventional cardiology council said that if the FDA was still persuaded to clear this device operators might struggle to “figure out which patients are those that this valve may be useful in.” I would be using this valve routinely as opposed to the valves that we already have.” Todd Neale is the Associate News Editor for TCTMD and a Senior Medical Journalist One-year outcomes of Acurate neo2 vs approved TAVR devices in all-risk patients with severe AS: the ACURATE IDE trial and topical videos covering the spectrum of CVD and presentations from major meetings right to your inbox TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF) CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the quality of their patients’ lives New at TCTMD? Register today! Forgot Password Enter the email you used to register to reset your password Sign up to receive the most important cardiovascular news This content is available for meeting attendees and/or Platinum Members Advanced Search News Microsoft has launched a public preview of its AI-powered coding assistant further expanding its AI ecosystem into the widely used open-source Eclipse IDE The move marks another step in Microsoft's push to integrate AI-assisted development across multiple platforms including those traditionally outside its ecosystem "We are excited to announce the Public Preview of GitHub Copilot for Eclipse," Microsoft said in a statement "As part of the broader GitHub Copilot family which enhances productivity in various IDEs this latest integration ensures that developers using Eclipse can benefit from AI-assisted coding like never before." though it supports multiple programming languages The Copilot integration brings real-time AI-powered code completion The GitHub Copilot assistant for Eclipse will offer: While the Copilot Chat feature is not yet available in this preview Microsoft has indicated further updates will follow The Eclipse IDE joins a growing list of platforms now supporting GitHub Copilot Microsoft is broadening its AI footprint into the open-source Java development ecosystem an area where it competes with Oracle and other Java-focused vendors Microsoft's move reflects a broader trend of AI-driven software development as major tech firms race to integrate machine learning and automation tools into developer workflows While Copilot was initially tied to Microsoft's own Visual Studio ecosystem and Xcode suggests a wider industry push to integrate AI across diverse development environments More Tech Library More Webcasts Problems? Questions? Just want to say "Hi"? Email us! When deciding which IDE for Python to download and use as different platforms can offer different sets of tools and usability some Python IDE's are dedicated to running only Python scripts and therefore have more dedicated tools while other platforms may offer coding across a number of different programming languages and offer less specialist tools Therefore do ensure you have a good idea of which features you think you may require from your IDE Integrated Development Environment for Python coding to make it simple and easy to use an Integrated Development Environment for coding with Python While very simple programs don't require specialist tools once past that stage some form of IDE becomes necessary but there are a number of different types and some are better at supporting some languages than others some IDE's have limits on how much code you can use while paid-for IDE's allow for much more freedom there are also paid-for tools that aim to offer more Whichever Python IDE you choose to run with at a minimum you'll want an application that does syntax highlighting has some awareness of the constituent source files of a project More advanced features might include code suggestions Here we feature the best IDEs for Python that are currently available We've also listed the best online courses for learning Python Python's very own bespoke Integrated Development Environment IDLE (named after Monty Python's Eric Idle) is fairly minimal compared to some of the other offerings around but it has everything you need and certainly won't get in your way It’s coded in Python and uses the lightweight tkinter toolkit to draw its GUI just as you get when starting Python from the terminal You can play around with code snippets here with the bonus that keywords and output will be nicely colored Moving on from here you can open a new window to start coding proper Your code will be appropriately highlighted and automatically indented IDLE supports using spaces or tabs for indentation and can automagically convert between the two – plus it can indent multiple lines at a time IDLE lacks any project management facilities but that’s no problem if your project spans only a handful of files It has a powerful debugger which allows single-stepping through the code or over-stepping through each high level function The debugger shows the call stack as well as the state of local and global variables Visual Studio Code – or Code for short – is an open source code editor owned by Microsoft and it's a fine choice for your Python projects too once you've installed the Python extension and has integration with all manner of source control tools and a well-stocked extensions marketplace (don't worry It can also run and debug your project's unit tests through the unittest it also has a minimalist 'zen mode' which shows you only the file you're working on and it has a settings panel that will delight those of a certain mind-set – each section unfolds the corresponding section of the settings.json file Unlike Atom it has support for Intellisense this also provides on-the-fly popups showing the documentation for classes and methods Read our full Visual Studio Code Review This powerful cross-platform IDE – which is named after Eric Idle – is written in Python and uses the Qt library It supports the bread and butter tasks we've come to expect: code folding But there's so much more that you'll need to use its built-in (and automated) TODO list generation to keep track It has an integrated class browser and powerful debugger and thanks to being built-in Qt supports building GUIs via Qt Designer The initial configuration screen may seem daunting there's no reason you can't use Eric as a simple code (or even plaintext) editor But it really comes into its own for more serious coding – there's even a built-in hex editor It supports unit tests and can debug both multithreaded and multiprocessing programs which as anyone who dabbles in such things will testify It supports Mercurial and SVN version control natively and Git support is available through a plugin there's support for real-time collaboration on code if you want a feature-rich Python powerhouse Thonny is the least ‘developer-centric’ of all the IDEs we’ve highlighted here but that doesn't mean it's any less powerful It's developed at the University of Tartu in Estonia It features a powerful debugger that's great for learning the ins and outs of coding without worrying about how breakpoints work The debugger can show you the state of variables as the program runs It lets you take small or large steps through the program which is great if you’re tracking down hard to find bugs This is much better practice than – as beginners and seasoned coders alike are occasionally tempted to do – peppering your code with messy print() statements Thonny will automatically indent as you type which is helpful for anyone new to Python since the language uses indentation to delineate functions It will autocomplete your code and provide bracket/parentheses matching It will also helpfully highlight any syntax errors but for the fact it's a little tricky to install if you're unfamiliar with Python packages and in particular pip (a package manager for Python) it is included as standard in new versions of Raspbian and is well-suited to Raspberry Pi projects It's just a shame that other distros don't include Thonny in their repos PyDev is the Python IDE that runs in Eclipse which is already a very popular open source IDE for various programming languages and is well-supported with a wide range of plugins to help add features PyDev itself comes with a range of useful coding features There's also an integration option to work with the Django Python web framework as well as offering support for Jython and IronPython development it's that there's so much coding support made available that some users might find it somewhat bloated it remains one of if not the most popular of the open source Python IDE's for exactly the same reason and easily provides enough features to support basic to intermediate programming LiClipse is a paid-for tier that runs with Eclipse to offer more customized options Wing IDE 101 is a simple and free Python IDE intended to help new programmers get used to coding in Python There are a number of resources to help with training and Wing IDE 101 is available for download for Windows CodeSkulptor is a browser-based IDE for Python The aim is to provide an easy to use platform for people new to Python to practice their programming skills This makes it especially ideal for groups to use as it means they will be using the same version and code editor and this is made all the more helpful by users not having to download and install software directly PyScripter is an open source IDE that includes many of the basic required features integrated Python interpreter and debugger as well as the ability to customize and run a Python script externally PyCharm is a Python IDE for professional developers provided by JetBrains and a huge collection of developer tools included We’ve also chosen the best laptop for programming. To test for the best IDE for Python we first set up an account with the relevant software platform We then tested the service with a variety of different scripts to see how the software could be used for different purposes and in different situations The aim was to push each IDE for Python to see how useful its basic tools were and also how easy it was to get to grips with any more advanced tools Read how we test, rate, and review products on TechRadar Sign up to the TechRadar Pro newsletter to get all the top news features and guidance your business needs to succeed the RL78 Family has supported the Arduino environment as a compatible board for about 10 years Arduino compatibility has been the standard for evaluation boards The RL78/G23-64p Fast Prototyping Board is the first board in the RL78 Family to offer access to all pins and an Arduino UNO compatible interface However previous users had to manually add the RL78 to the BOARDS MANAGER when using the Arduino IDE.The RL78/G23-64p Fast Prototyping Board and RL78/G22 Fast Prototyping Board have now been added as standards to the BOARDS MANAGER in the Arduino IDE lowering the bar for development even further.Try typing "RL78" in BOARDS MANAGER in the Arduino IDE version.You will see the information for RL78/G23-64p Fast Prototyping Board and RL78/G22 Fast Prototyping Board You can see the values acquired from the HS3001 sensor on the Arduino IDE on the serial monitor!We will continue to expand the application notes for Arduino The Renesas Engineering Community (user community page) also lists Arduino-compatible software Arduino is a registered trademark of Arduino™ SA.All product and service names in this release are trademarks or registered trademarks of their respective owners and solutions delivered straight to your inbox AWS Step Functions introduces an enhanced local IDE experience to simplify building state machines. Workflow Studio is now available within Visual Studio Code (VS Code) through the AWS Toolkit extension developers can author and edit state machines in their local IDE using the same powerful visual authoring experience found in the AWS Console Step Functions is a visual workflow service that helps developers use AWS services to build distributed applications and create data and machine learning (ML) pipelines Developers maintain their workflows definitions alongside the application and Infrastructure as code (IaC) code builders have even more capabilities to build and test their workflow in VS Code that matches the same experience as in AWS console The integrated Workflow Studio provides developers with a seamless experience for building Step Functions workflows within their local IDE You’ll use the same canvas used in the AWS Console to drag and drop states to build your workflows so you can focus on business logic rather than syntax The Workflow Studio integration offers the same intuitive and visual approach to designing state machines as the AWS Console To use the updated IDE experience, verify that you have the AWS Toolkit with at least version 3.49.0 installed as a VS Code Extension After installing the AWS Toolkit extension, you can start building with Workflow Studio by opening a state machine definition. You can use a definition file from your local workspace or use AWS Explorer to download an existing state machine definition from the cloud VS Code integration supports ASL definitions in JSON and YAML formats asl.yml or .asl.yaml for Workflow Studio to automatically open the file.) While working with YAML files Workflow Studio converts the definition to JSON for editing To open Workflow Studio in VS Code manually you can use the “Open with Workflow Studio” action at the top of a workflow definition file or the icon in the top right of the editor pane Both options are highlighted in the following screen you can use the file context-menu to open Workflow Studio from the file explorer pane Figure 4: Integrations of Workflow Studio into the editor Edits you make in Workflow Studio are automatically synced to the underlying file as unsaved changes you must either save the changes from Workflow Studio or the file editor any changes you make to the local file are synced to Workflow Studio on save Workflow Studio is aware of Definition Substitutions, so you can even edit workflows which have been integrated with your IaC tooling like AWS CloudFormation or the AWS Cloud Development Kit (CDK) Definition Substitutions is a feature of CloudFormation that lets you add dynamic references in your workflow definition to a value that you provide in your IaC template You can then use the Definition Substitutions in the definition of your state machine The code defines a Step Functions task state that writes a message to DynamoDB using the putItem operation The ${TableName} substitution syntax allows for a dynamic DynamoDB table name that can be passed as a parameter when the state machine is executed Workflow Studio integration supports testing a single state through Step Functions TestState API you can test a state in the cloud from your local IDE without creating a state machine or updating an existing state machine With the power of localized granular testing you can build and debug changes for individual states without needing to invoking the entire state machine you can refine the input or output processing or update the conditional logic in a choice state without ever leaving your IDE Figure 6: TestState configuration with a Definition Substitution After the test succeeds, you can publish your workflow from the IDE using the AWS Toolkit. You can also use IaC tools such as AWS Serverless Application Model or CloudFormation to deploy your state machine Step Functions is introducing an enhanced local IDE experience to simplify the development of workflows using the VS Code IDE and AWS Toolkit This streamlines the code-test-deploy-debug cycle and offers developers a seamless integration of Workflow Studio By combining visual workflow design with the power of a full-featured IDE developers can now build Step Functions workflows more efficiently To get started, install the AWS Toolkit for Visual Studio Code and visit the user guide on Workflow Studio integration. Find hands-on examples, best practices, and useful resources for AWS serverless at Serverless Land JetBrains is abandoning its plan to build an IDE for Kotlin Multiplatform (KMP) on Fleet in favour of improved KMP features for its mature IntelliJ IDE causing developers to question the future of Fleet itself Hadi Hariri, JetBrains VP of program management, said that the company intended two years ago to create a standalone IDE for KMP based on Fleet but that feedback from customers demanded KMP support for IntelliJ Android Studio is built on the free community edition of IntelliJ IDEA Hariri further said that support for KMP in Fleet is being deprecated altogether in the next three months and there are no longer any plans for a dedicated KMP IDE “This makes me worried for Fleet’s future,” said a developer commenting on Hariri’s post KMP developers were generally positive about the news “You listened to the community … whatever Fleet’s future may be … it doesn’t have the near-term readiness to support KMP that’s already been demonstrated by the IntellJ platform.” KMP, which targets iOS, Android, web and desktop platforms, received a boost at Google’s I/O event in May 2024, when Google gave KMP official support It makes sense that Google would prefer to see KMP supported in Android Studio Fleet was introduced in late 2021 and has been in preview ever since with features including strong collaboration and remote development support and a minimalist UI that is reminiscent of Microsoft’s Visual Studio Code (VS Code) A new “islands” UI was added late last year visually separating the editor and tool panels to make Fleet more modular Maintaining two separate IDE families is expensive and when Fleet was first announced, it seemed possible that it might one day be the primary JetBrains IDE platform. Today that looks unlikely. A developer on Hacker News claimed to have “talked to a Jetbrains representative at a conference about this They said Fleet was/is an experiment in the realtime collaboration tech They said it is no longer seen as a good direction internally DC—A newly approved drug-coated balloon (DCB) for the treatment of in-stent restenosis (ISR) continues to be safe and effective with fewer events and repeat interventions compared with balloon angioplasty The Agent DCB (Boston Scientific) offered a lower rate of target lesion failure—the composite of ischemia-driven TLR or cardiac death—than did an uncoated balloon (27% vs 34%; P = 0.04) “Consistent results were observed on the 2-year follow-up with a significantly reduced instance of target lesion failure with a 37% [relative risk] reduction,” Jeffrey W MD (NewYork-Presbyterian/Columbia University Irving Medical Center No cases of definite and probable thrombosis were seen in patients who received the DCB The device, which is coated with a low dose of paclitaxel, became the first coronary DCB in the United States to be approved for the treatment of ISR last year on the basis of early data from the AGENT IDE trial told TCTMD the 2-year results are “reassuring but perhaps not as durable as one might want to see in the real world.” MD (Icahn School of Medicine at Mount Sinai noted that some “may quibble about whether or not there’s a little bit of a late catch-up” in the 2-year TLF rates which had been 18% in the DCB group and 29% in the uncoated-balloon group at 1 year he stressed that while these data pitted the DCB against plain old balloon angioplasty (POBA) the DCB is a welcome option for many operators who are hesitant to add another layer of stenting in a previously stented artery when confronted with multiple layers “In smaller vessels it’s a matter of real estate,” he added “As far as the first restenosis in a large vessel we’ll have randomized data to help guide us in the future.” noted that the European Society of Cardiology (ESC) recently changed their recommendations downgrading the evidence for DCB for in-stent restenosis and giving the first-line treatment recommendation to repeat DES Long-term follow-up studies did not show a benefit of DCB over DES which was the issue for the ESC task force given limited head-to-head data to go on Guidance and class recommendations come from randomized clinical trials,” she said AGENT IDE randomized 600 patients (mean age 68 years; 26% female; 7% Black) to treatment with the DCB or POBA The cohort had high rates of diabetes (51%) multiple prior stents were present at the site of the target lesion Patients were enrolled if they had ISR of a lesion previously treated with BMS or DES that was < 26 mm in length and between 2.0 and 4.0 mm in reference vessel diameter Symptomatic patients were enrolled if they had target lesion stenosis < 100% but greater than 50% and asymptomatic patients were enrolled if they had target lesion stenosis > 70% Conventional angioplasty techniques were used in all patients prior to randomization to the low-dose paclitaxel-coated DCB or uncoated balloon Intravascular imaging was used in 72% of those in the DCB arm and 77% of those in the uncoated balloon arm in the United States where this device costs about $5,000 86% of those in DCB arm were still on aspirin and 84% and 68% were still on dual antiplatelet therapy (DAPT) TLR was less frequent in the DCB group (HR 0.56; 95% CI 0.40-0.80) out to 24 months Stone noted that the DCB is pricier than a DES raising issues of whether and how to control costs of these procedures while offering the most benefit to the patient said the “sweet spot” for Agent may be as a go-to option after a second stent Cohen agreed that in the case of two stents and unfortunately in the United States where this device costs about $5,000 it’s not a big issue [because] it costs about $500,” he added it’s problematic for [US] operators when it’s so expensive and it’s not necessarily reimbursed.” Cohen noted that although the Centers for Medicare & Medicaid Services recently approved an additional reimbursement for the DCB it still remains out of reach for many US patients Hermiller added that the reductions seen in repeat TLR in the AGENT IDE trial are pertinent to the economic discussion and should be studied further “It’s relevant to the patient and it’s important to the hospital as well in terms of cost,” he said L.A. McKeown is a Senior Medical Journalist for TCTMD, the Section Editor of CV Team Forum Paclitaxel-coated balloon versus uncoated balloon for coronary in-stent restenosis: two-year outcomes of the AGENT IDE trial Looking for the best IDE for React Native development each packed with features to boost your productivity and streamline your workflow Integrated Development Environments (IDEs) are more than just tools; they are the backbone of modern software development An IDE combines various development tools into a single The right IDE typically includes several key components: a source code editor These elements streamline the development process making it easier to manage complex projects IDEs are essential for React Native developers optimizing both coding and development processes and project management tools are part of the intelligent code assistance they offer making it easier to choose the right IDE for React Native This integration enhances productivity, allowing developers to focus on writing high-quality code without being bogged down by mundane tasks. Supporting multiple programming languages and frameworks, IDEs offer the flexibility needed for various projects, making them indispensable in the software development life cycle Choosing the right IDE can transform your React Native development experience into a more efficient and enjoyable one Here is a detailed look at the top IDEs for React Native development in 2024 offers unique features designed to enhance productivity and streamline workflow Visual Studio Code (VS Code) stands out as the preferred choice among developers with 73.71% of the React Native community opting for it Its popularity is no accident; VS Code offers a robust set of features that cater specifically to React Native development and intelligent code suggestions via IntelliSense The React Native Tools extension provides tailored IntelliSense making it a powerful integrated development environment for React Native projects A major reason for VS Code’s widespread use is its extensive extension marketplace Developers enhance their workflow by adding language support and Windows makes it accessible to a wide range of developers VS Code’s performance and flexibility make it an excellent choice for both beginners and experienced developers. Its extensive plugin ecosystem and community support allow you to tailor your development environment to your needs, ensuring a seamless and productive coding experience is renowned for its advanced features and comprehensive support for JavaScript It offers intelligent code assistance with features like code completion These features make it ideal for developers working on large WebStorm’s built-in version control system This integration simplifies project management and enhances team collaboration WebStorm’s integrated terminal and customizable UI create an accessible and efficient development environment justifies the investment with its powerful features and extensive plugin ecosystem make WebStorm a worthy competitor to free options like VS Code offering a seamless development experience for React Native developers Atom is an open-source text editor created by GitHub It is recognized for its adaptability and many customization options Developers can personalize their editing environment through an extensive library of community-developed packages This flexibility makes Atom a versatile choice for various development needs Atom supports a wide range of plugins and packages designed for React Native development. Its beginner-friendly nature makes it accessible to those new to React Native, providing an easy entry point into mobile app development Community-driven plugins enable developers to extensively tailor their environment ensuring they have the tools needed to succeed and customizable functionalities catering to developers’ needs Its beginner-friendly interface makes it an excellent choice for new developers looking to start coding quickly The split editing feature allows users to divide the editor into multiple panes improving workflow by enabling simultaneous work on different files or sections The Goto Anything feature in Sublime Text enhances efficient coding by allowing quick navigation to files or symbols the Command Palette streamlines the development process by enabling users to execute commonly used functions quickly make Sublime Text a powerful tool for React Native development IntelliJ IDEA is recognized for its robust tools that enhance coding efficiency and debugging capabilities in React Native projects Key features include intelligent code analysis and an extensive plugin ecosystem tailored for React Native development These features make IntelliJ IDEA a powerful integrated development environment for large-scale applications Customization options in IntelliJ IDEA are extensive Its advanced debugging tools streamline the process of identifying and resolving issues in React Native applications The Community Edition of IntelliJ IDEA is free and open-source making it accessible for developers to leverage its features without cost Android Studio is particularly suitable for crafting and testing React Native apps specifically for the Android platform It supports crucial tools such as package managers These tools make it an ideal choice for Android-specific projects it may not provide the same level of support as dedicated IDEs such as Visual Studio Code or WebStorm Its comprehensive tools and support for native development make it a valuable asset for developers focusing on Android app development within React Native code Expo simplifies the deployment and development of React Native applications making it an excellent choice for rapid prototyping and smaller applications and a command-line interface for React Native development These features simplify the development process and enhance productivity The primary benefit of using Expo is its user-friendly CLI which streamlines the process of initiating and managing applications This makes Expo ideal for developers looking to quickly build and deploy React Native applications without extensive setup an open-source IDE developed by Facebook and built on the Atom editor is known for its remote development and debugging capabilities These features make it suitable for React Native projects providing developers with the necessary tools for efficient work Nuclide offers support for multiple programming languages The combination of Atom’s customizability and Nuclide’s robust features makes it a powerful tool for React Native development Its open-source nature allows developers to tailor their environment to their specific needs ensuring a seamless and productive coding experience Choosing the right IDE involves considering factors like project size Each IDE offers unique benefits that cater to various needs and selecting the right one can significantly impact productivity and workflow Visual Studio Code and Atom are excellent choices for those seeking extensive customization and community support WebStorm and IntelliJ IDEA are suitable for larger more complex projects due to their robust features and advanced debugging tools Android Studio is ideal for Android-specific development while Expo is perfect for rapid prototyping and smaller applications Assessing your project requirements and personal workflow will help you choose the right IDE for creating exceptional cross-platform mobile applications Optimizing your development environment is key to maintaining productivity and ensuring a seamless development experience. Strategies like dynamic imports, which load code on-demand, optimize bundle size, and improve performance. Offloading heavy computations to background threads keeps the UI responsive, enhancing the user experience Implementing caching strategies reduces the need for frequent data retrieval Lazy loading components can significantly reduce initial loading time assessing its performance and ease of use ensures it fits seamlessly into your development workflow Debugging tools are crucial for identifying and resolving issues in React Native applications Many IDEs provide integrated debugging tools enabling a React Native developer to troubleshoot issues without leaving their coding environment Tools like LogBox provide immediate feedback on errors while React Native DevTools enable inspection of JavaScript code execution Profiling tools like React Native Debugger and Firebase Performance Monitoring help monitor performance metrics, identify bottlenecks, and maintain optimal application performance These tools are invaluable for ensuring your React Native applications run smoothly and efficiently Plugins and extensions enhance productivity by extending the functionality of React Native IDEs Intelligent code completion provided by extensions significantly speeds up coding processes allowing developers to write code more efficiently Pre-configured environments streamline the setup process saving time on manual library and framework installations Community-driven plugins for Atom enable developers to extensively customize their development environment tailoring it to their project requirements Some IDEs offer real-time collaboration features allowing multiple developers to work seamlessly on the same project simultaneously These enhancements ensure a seamless integration of advanced features providing a productive and efficient development experience Choosing the right IDE for your React Native development can significantly impact your productivity and the quality of your code Each IDE discussed offers unique features and benefits catering to different project needs and development styles By understanding the strengths of tools like Visual Studio Code you can make an informed decision that enhances your development experience The right IDE can unlock the full potential of React Native enabling you to create standout mobile applications Whether you’re prototyping a new idea or building a large-scale project the right tools will support your journey every step of the way Visual Studio Code's popularity for React Native development stems from its rich extension ecosystem and intelligent code suggestions with IntelliSense Its lightweight and cross-platform nature further enhances its accessibility for developers You should consider WebStorm for your large React Native projects due to its intelligent code assistance all of which significantly enhance productivity and streamline project management These advanced features are specifically designed to handle the complexities of large projects effectively Atom caters to beginners in React Native development by providing an intuitive interface and a wealth of community-developed packages that enhance accessibility and adaptability This makes it an excellent choice for new developers to start their journey with React Native IntelliJ IDEA offers intelligent code analysis and robust debugging tools which significantly enhance the React Native development experience its extensive plugin ecosystem and free Community Edition make it a versatile and accessible option for developers Optimizing your development environment is crucial as it enhances performance By implementing strategies like dynamic imports and caching you can significantly improve your workflow efficiency Discover the top options and their features in this Node.js IDE guide Node.js IDEs enhance development efficiency by integrating essential features such as code completion streamlining workflows and improving code quality Popular Node.js IDEs for 2025 include Visual Studio Code each offering unique capabilities tailored to various development needs Choosing the right Node.js IDE involves considering factors such as licensing which significantly influence development workflow and project success An Integrated Development Environment (IDE) is more than just a code editor It combines several essential features into one cohesive application Additional features such as code navigation tools These elements work together to create a streamlined development process reducing errors and facilitating collaboration among developers IDEs enhance the development process by improving workflows and reducing errors ultimately leading to simpler and faster application development enhances code writing and testing efficiency and facilitates collaboration among team members by integrating all necessary tools into one platform a Node.js IDE supports specific programming languages offering tools that cater to the unique needs of Node.js development such as smart code completion and intelligent code assistance Using various node js ides can enhance the overall experience for developers One of the standout benefits of using a Node.js IDE is the ability to transition seamlessly from one task to another and version control systems into one environment streamlines workflow and boosts productivity This integration not only reduces the time spent on manual tasks but also improves the overall quality of the code ensuring that projects are completed on time and within budget A specialized Node.js IDE optimizes the entire software development lifecycle (SDLC) and offer context-aware suggestions to enhance coding accuracy and speed Leveraging a Node.js IDE can result in higher code quality and faster js development cycles making it invaluable for any js ides developer Key features to consider when selecting a Node.js IDE include intelligent code completion Each feature plays a vital role in enhancing the development process and ensuring the success of Node.js projects Smart autocomplete in Node.js IDEs predicts what a developer will type based on context Known as intelligent code completion or IntelliSense this feature helps by suggesting relevant code snippets and functions as developers type Advanced IDEs provide auto-suggest during typing reducing development time and enhancing code quality Text completion boosts productivity by minimizing the need for manual code typing This assistance speeds up coding and helps maintain code readability and consistency facilitating collaboration and large project management Debugging tools identify and resolve code issues Integrated debugging tools in Node.js IDEs allow developers to set breakpoints enabling developers to diagnose and fix issues more efficiently Efficient error detection and real-time code testing streamline debugging These tools ensure error-free code and expected performance improving application quality and reliability Version control integration is vital in any Node.js IDE and resolve merge conflicts within the IDE Seamless integration with version control systems like Git allows developers to manage code changes and collaborate effectively Facilitating code changes and collaboration version control integration improves workflow and keeps team members aligned This feature is crucial for maintaining codebase integrity and consistency especially in larger projects with multiple developers Looking ahead to 2025, several Node.js IDEs stand out for their features, performance, and community support. These IDEs offer powerful development tools Here are the top Node.js IDEs for 2025 and what makes them exceptional Microsoft created Visual Studio Code as a Node.js IDE It is free to use and is recognized for its wide range of features Its extensive plugin and extension ecosystem enhances functionality allowing developers to tailor their development environment The user-friendly interface and low learning curve make Visual Studio Code an excellent choice for beginners and split views boost productivity by fostering focused and collaborative coding Whether you are working on a small project or a large-scale application Visual Studio Code offers the tools and flexibility needed to succeed WebStorm, a dedicated IDE for JavaScript and Node.js, is tailored for web development and debugging tools make it a superior choice for web development projects providing versatility for various web development needs WebStorm offers advanced features like code analysis and refactoring It also provides built-in tools for timely coding including quick documentation lookups and version control support WebStorm’s focus on web development functions and plugins makes it an excellent choice for developers looking to build robust web applications highly customizable IDE with a user-friendly interface It offers customizable configurations with four separate UIs and eight syntax themes allowing developers to tailor their development environment to their preferences Atom’s extensive plugin library enhances its functionality making it a popular choice among developers The plugin ecosystem enhances Atom’s flexibility supporting a broad range of programming languages This makes Atom suitable for various development needs from small personal projects to large-scale applications Sublime Text is known for its speed and responsiveness due to its proprietary components It allows developers to work on multiple projects simultaneously with split editing capabilities This is particularly useful for managing large codebases and handling files efficiently making it versatile for various development tasks Its lightweight nature and powerful editing features make Sublime Text a solid choice for Node.js developers looking for a fast and efficient code editor provides a comprehensive development environment for Node.js applications The Nodeclipse plugin extends Eclipse’s capabilities for Node.js development and customizable plugins for Node.js projects This IDE benefits teams managing large projects with its robust features and collaborative tools Eclipse’s refactoring options and key binding editor further enhance developer efficiency making it a powerful tool for Node.js development Cloud9 IDE, used for creating applications with JavaScript frameworks like Node.js One of its significant collaborative features is real-time collaboration allowing multiple developers to work on a codebase simultaneously This feature is particularly useful for distributed teams and remote work environments The IDE includes tools like integrated debugging and live preview functionalities that facilitate real-time coding making Cloud9 IDE an excellent choice for collaborative Node.js projects includes predictive technology that anticipates developer intent Developers can compile and execute code directly from the js ide they can also debug their code within the same environment Installing the Node.js plugin in IntelliJ IDEA provides access to specific capabilities tailored for Node.js development The Node.js plugin is crucial for accessing IntelliJ IDEA’s full suite of features for Node.js development This IDE’s comprehensive toolset and predictive technology make it a powerful choice for developers looking to streamline their workflow and improve productivity catering to various development needs and supporting multiple programming languages This makes it ideal for diverse development projects Komodo IDE includes strong debugging tools that assist developers in identifying and resolving issues efficiently Support for various programming languages and robust debugging tools make Komodo IDE a solid choice for developers seeking a versatile and powerful programming language environment Whether you’re working on simple scripts or complex applications Komodo IDE offers the tools you need to succeed Free and open-source Node.js IDEs provide accessible options for developers at all levels These IDEs provide robust features and community support making them ideal for various development projects without the cost barrier Vim is a highly configurable text editor favored for its efficiency in text editing and programming It supports syntax highlighting for JavaScript enhancing code readability and helping identify errors during Node.js development Vim’s powerful command-line interface streamlines the development workflow Vim can integrate with plugins to enable features like autocompletion and linting it allows developers to modify the source code and adapt it to their specific needs making it a flexible and powerful tool for Node.js development Atom is an open-source and free IDE that allows developers to customize their development environment It features a user-friendly interface and high customizability Atom’s extensive package ecosystem allows users to enhance its functionality with community-created packages making it versatile for Node.js development Eclipse Che provides shared workspaces for collaborative development It supports modern development tools and features a RESTful API server for easy integration with other tools Eclipse Che’s collaborative workspaces enhance productivity and create a conducive environment for Node.js development Choosing the right Integrated Development Environment (IDE) is critical for efficient coding in Node.js development Understanding different Node.js editors helps developers choose the right tools and informs clients about the technology an IDE with shared tools and features can enhance teamwork and reduce plugin compatibility issues is particularly well-suited for large projects that involve several organizations and numerous people due to its robust features and collaborative tools the right integrated development environment significantly impacts development workflow making it crucial to choose an IDE that aligns with project needs and team dynamics Whether you prioritize intelligent code completion the right IDE will streamline your development process and ensure the success of your Node.js projects selecting the right Node.js IDE is crucial for enhancing productivity offer a range of features such as intelligent code completion These tools not only streamline the development process but also foster collaboration among developers As you embark on your Node.js development journey consider the specific needs of your project and team By leveraging the capabilities of these powerful IDEs Make an informed decision and choose the IDE that best fits your development goals and workflow and seamless version control integration in a Node.js IDE for an enhanced coding experience These features will significantly improve your development workflow Visual Studio Code is a popular choice for Node.js development because of its robust debugging features excellent support for TypeScript and JavaScript its extensive range of plugins enhances productivity and customization WebStorm is tailored for web development by providing intelligent code completion These features enhance coding efficiency and streamline the development process Atom's flexibility stems from its extensive customization options and a wide array of plugins making it suitable for various programming languages and user needs This adaptability allows developers to tailor their environment effectively Choosing the right Node.js IDE is crucial for project success as it enhances productivity and leads to more efficient project completion Contact:Heather LeeState Park Interpreter(530) 529-8599 RED BLUFF – California State Parks and its partner, Ide Adobe Interpretive Association, invite everyone to get in the holiday spirit with Holidays on the Homestead at William B. Ide Adobe State Historic Park (SHP) The park’s 45th annual festive winter tradition will be celebrated on Saturday Visitors can participate in various family-friendly activities such as making ornaments and gifts and dancing to music Ide Adobe State Historic Park 21659 Adobe Road CA 96080 COST: Adults - $6 Children 3 years and up - $3 Children under 3 - free Families (up to 5 guests) - $15 • Enjoy living history demonstrations with staff and volunteers dressed in 1850s clothing • Visit Santa Claus at the homestead to tell him your holiday wishes.• Make handmade gifts • Enjoy warm wassail and some yummy treats California State Parks supports equal access. For more information about the event or if members of your group have accessibility needs, please contact the park at (530) 623-5284 in advance to arrange accommodations. You can also get updates by following William B. Ide Adobe’s Facebook page.   Visitors at last year’s event enjoying refreshments and living history demonstrations.Photos from California State Parks Subscribe to California State Parks News via e-mail at NewsRoom@parks.ca.gov California State Parks provides for the health inspiration and education of the people of California by helping to preserve the state’s extraordinary biological diversity protecting its most valued natural and cultural resources and creating opportunities for high quality outdoor recreation Sign up to receive the latest State Parks news directly to your email Have a question? Use the Contact Us Page. © Copyright document.write(new Date().getFullYear()); Coding agents are now available in VS Code and JetBrains IDEs expanding developer tool choices as the AI agent trend gains mainstream momentum GitHub Copilot agent mode became generally available April 4, including a tie-in with Microsoft's Visual Studio Code integrated development environment (IDE). This week, JetBrains made its Junie coding agent available to users of its IDEs Coding agents were already available from vendors such as Windsurf and Cursor. Atlassian also introduced a coding agent with an update to its Rovo product this month. JetBrains and Atlassian both adjusted pricing to fold AI agents into existing subscriptions which for JetBrains includes a free tier limited to local AI models With AI agents, unlike the previous generation of AI coding assistants that provided inline code snippet suggestions developers can delegate whole tasks with a natural language prompt such as "Create a web application in Python." "It's a very early form of agentic AI," said Diego Lo Giudice Truly agentic AI networks involve multiple agents working autonomously to carry out multi-step workflows and solve complex problems. However, the wider infrastructure to support agentic AI is still being built with projects such as Model Context Protocol For now, these "agentish" systems, as Lo Giudice calls them, will generate more significant portions of code than the previous crop of coding assistants, and some will start connecting tasks in the software development lifecycle "That's what getting more agentic will improve over time -- pulling together more complex software development workflows," he said "You now have the full process of going from an issue to code and you can basically submit the pull request and then move on from there." An initial demo of GitHub Copilot agent mode showed promise for one GitHub Enterprise user but it still requires a skilled and experienced human to oversee it "I gave it a task of refactoring some code and it broke some stuff around it," said Kyler Middleton principal software engineer at healthcare tech company Veradigm the agent continued to fix what it had broken but introduced new errors "It has refactored the code in such a way that it doesn't even look like my original code and it keeps introducing problems," she said "It is not successfully finishing the task -- it's been running for 90 minutes Middleton said the coding agent concept is also very different from using a coding assistant but I still feel like I'm the primary author of the code which is what Copilot aims to do," she said "This agent mode is more like having a junior engineer writing code for you … and you provide feedback With the release of Copilot agent mode to general availability GitHub also introduced public preview support for Model Context Protocol which connects coding agents to data sources and secondary tools that ground them in a user's specific context boosting the quality of the code they produce GitHub is "all in on agent mode and shipping updates daily," according to a company spokesperson in an emailed statement to Informa TechTarget "Early data suggests enthusiasm and significant growth in daily usage There are still many improvements we're delivering to make agent mode even better and we look to user feedback to help guide our ongoing investments." Generating code has been among the most effective uses for generative AI so far "While the accuracy has improved over the years but based on my conversations with many enterprise developers it cuts down the coding time tremendously," Thurai said "Especially when developers are racing against time during a major incident to roll out a fixed code quickly and have the systems back up and running there is still the risk that what coding agents produce could add to tech debt over time; enterprises are starting to use code profiling and other validation techniques to reduce this issue But while that may be helpful for startups looking to quickly develop a prototype app enterprises won't be able to vibe code their way into a scalable reliable production application -- at least so far "It will definitely enhance prototyping and innovation in companies but then somebody is going to have to go and do the rest of the work for turning that into a real "That's going to be done by true developers Beth Pariseau, a senior news writer for Informa TechTarget, is an award-winning veteran of IT journalism covering DevOps. Have a tip? Email her or reach out @PariseauTT Developers can use Amazon Lightsail to quickly build websites and applications Once admins have acknowledged the cloud skills gap within their team Cloud programming languages are not one-size-fits-all Learn about the top cloud programming languages Successful pseudocode conversion goes beyond simply making the code work It's about creating implementations that respect each .. Discover how organizations can streamline operations and improve operational analytics by using AI and machine learning in their .. Can you teach an old programming dog a new trick According to FreedomPay's performance guru GenAI will allow IT ops pros to experiment with ideas for performance optimization .. Our guide to the annual Red Hat Summit keeps you up to date on trends An API security specialist's newly launched WAAP product outranked more established WAF competitors during independent benchmark .. This walkthrough explains what AI agents can do In today's world of web application development and SaaS what does the future hold for Java desktop applications Want to unlock the power of AI in your Java applications This walkthrough guides you on how to use OpenAI and Java with large .. Many organizations struggle to manage their vast collection of AWS accounts There are several important variables within the Amazon EKS pricing model Dig into the numbers to ensure you deploy the service .. With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular Institute of the South successfully treats first patient in the U.S marking a milestone in advancing personalized care for PAD patients Amsterdam, the Netherlands – Royal Philips (NYSE: PHG today announced enrollment of the first patient in the U.S which will study an innovative combined laser atherectomy and intravascular lithotripsy catheter developed by Philips that integrates two critical PAD treatments into a single device Procedures that previously required the use of two different devices can now be performed in a single procedure using a single device simplifying workflows and procedures and potentially reducing the risk and improving outcomes for patients who might otherwise face multiple complex interventions.  The Cardiovascular Institute of the South in Louisiana recently completed the first case using the new laser catheter The care team there successfully treated a 78-year-old male with peripheral vascular disease using the Philips device “Developing and driving clinical evidence is crucial to improving care and guiding the adoption of new technologies like the Philips laser atherectomy and lithotripsy system,” said Drs and McCall Walker of Cardiovascular Institute of the South in Louisiana “This trial will provide essential data to demonstrate how this combined approach can optimize procedural efficiency and patient outcomes in treating challenging calcified lesions.” This ground-breaking first procedure not only marks the launch of the THOR IDE trial It also showcases how this innovative new technology which resulted from Philips’ powerful in-house development capabilities can ease the patient experience by streamlining complex interventions into a single procedure potentially reducing the need for multiple interventions and hospital visits The goal of this pivotal study is to evaluate the safety and efficacy of using this unique laser device — a first-of-its-kind solution that integrates laser atherectomy and intravascular lithotripsy in a single device to treat complex calcified lesions in a single procedure for patients with peripheral artery disease (PAD) PAD is a common and serious condition that affects millions of people worldwide particularly older adults and those with diabetes or high cholesterol It leads to reduced blood flow to the limbs Patients with calcified lesions represent a particularly challenging group as traditional treatment options often involve multiple steps and devices The Philips laser catheter integrates two critical PAD treatments into a single device significantly simplifying the treatment workflow – atherectomy to remove atherosclerotic plaque from the internal surface of an artery and intravascular lithotripsy to modify calcium deposits within the artery or disrupt calcium deposits in the artery wall The unique and highly innovative feature of the Philips catheter is that both the atherectomy and lithotripsy are laser-driven Compared to conventional intravascular lithotripsy devices which require the use of a separate ultrasound catheter to create calcium-disrupting sonic shockwaves the Philips device uses a pulsed laser to instantly vaporize fluid within the blood vessel to create bubbles that expand and then rapidly collapse generating the required sonic waves as they do so.   The prospective, single-arm, multicenter study will enroll up to 155 patients at up to 30 sites in the U.S Conducted under an Investigational Device Exemption (IDE) from the U.S it will assess the system's safety and effectiveness in achieving procedural success with a low rate of complications The study’s primary endpoints include freedom from major adverse events (MAEs) such as mortality and clinically driven target lesion revascularization (CD-TLR) within 30 days (about four and a half weeks) of the procedure as well as achieving less than or equal to 50% residual stenosis post-procedure “This innovative approach to vessel preparation could improve patient outcomes while minimizing the need for multiple therapies and interventions That makes this an exciting innovation milestone as we enroll the first patient in this important U.S vascular surgeon and co-principal investigator of the THOR* trial at the Penn Advanced Limb Preservation Hospital of the University of Pennsylvania “Integrating atherectomy and intravascular lithotripsy into a single device has the potential to revolutionize the treatment of patients with complex femoropopliteal lesions associated with moderate to severe calcifications.” added: “A result of Philips’ extensive in-house innovation and development capabilities our combined laser atherectomy and intravascular lithotripsy device reflects our commitment to providing physicians with the tools they need to tackle complex vascular challenges more efficiently and effectively potentially transforming treatment paradigms for peripheral artery disease.  Philips is dedicated to clinically validating its innovations through rigorous trials and does so in collaboration with strong clinical partners.” The Philips laser atherectomy and intravascular lithotripsy system is currently investigational and not yet commercially available anywhere in the world [1] Peripheral artery disease (PAD) - Symptoms and causes - Mayo Clinic AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home 0.0 MB - The innovative combined laser atherectomy and intravascular lithotripsy catheter developed by Philips you will be leaving the official Royal Philips ("Philips") website Any links to third-party websites that may appear on this site are provided only for your convenience and in no way represent any affiliation or endorsement of the information provided on those linked websites Philips makes no representations or warranties of any kind with regard to any third-party websites or the information contained therein You are about to visit a Philips global content page Philips and Ibex expand partnership to enhance AI-enabled pathology workflows for better patient care Philips and Mass General Brigham announce collaboration to improve patient care with live AI-powered insights Philips strengthens strategic partnership with Sim&Cure to expand innovation in neurovascular therapy Philips and Medtronic partner to advance global stroke care Siloam Hospitals Group and Philips sign AI capability MoU to support Indonesia’s healthcare transformation strategy Pioneering hospitals take major steps towards decarbonizing healthcare with Philips Our site can best be viewed with the latest version of Microsoft Edge 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) a leading global provider of medical technologies today announced that the preliminary results from its Ringer™ PBC IDE study were reported in a featured presentation at the CTO Plus Conference in New York by the study’s principal investigator Piedmont Heart Institute and Cardiovascular Services Interventional Cardiology at Piedmont Heart Institute Ringer™ PBC is a rapid-exchange percutaneous transluminal coronary angioplasty (PTCA) catheter with a unique helical balloon the balloon approximates a hollow cylinder with a large central perfusion lumen allowing for continuous coronary blood flow during prolonged inflations.1 The Ringer™ PBC study is a limited prospective undertaken at four sites in the United States investigating the Ringer™ PBC for the management of emergent coronary perforations that develop during percutaneous coronary intervention (PCI) procedures and analysis was performed based upon intention-to-treat The primary efficacy endpoint required successful Ringer™ PBC delivery and inflation at the perforation site control of extravasation (defined as residual Ellis grade 0 or 1) and preservation of antegrade coronary flow (Thrombolysis in Myocardial Infarction [TIMI] grade 2 or 3) the primary efficacy endpoint was observed in 22 participants (73.3%) with successful Ringer™ PBC delivery in 26 participants (86.7%) Among those participants with successful delivery control of extravasation with perfusion was achieved in 22 participants (84.6%) Twelve participants were treated with a covered stent following perforation management with the Ringer™ PBC One participant required emergency surgery for complications of pericardiocentesis and three participants died despite control of extravasation from the index perforation "I believe these preliminary study results are important,” said Dr “Treatment options for patients with coronary artery perforations during PCI cases have been limited to date and this trial points the way to developing dedicated devices.” For the investigational use of the management of coronary perforations Ringer™ PBC was granted the FDA’s Breakthrough Device Designation a program intended to provide patients and healthcare providers with timely access for certain medical devices that could potentially provide for more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions by speeding up development "Teleflex is committed to generating the clinical evidence to help physicians make confident decisions when selecting the right products for their patients’ needs,” said Teleflex Medical Director Ringer™ PBC is currently indicated for balloon dilatation of coronary artery or coronary bypass graft stenoses where the physician desires distal blood perfusion during balloon inflation for the purpose of improving myocardial perfusion The Ringer PBC in this study is an investigational device and not available for sale Data from the study is intended to support a premarket application recently submitted to FDA About Teleflex IncorporatedAs a global provider of medical technologies Teleflex is driven by our purpose to improve the health and quality of people’s lives Through our vision to become the most trusted partner in healthcare we offer a diverse portfolio with solutions in the therapy areas of anesthesia We believe that the potential of great people and world-class products can shape the future direction of healthcare UroLift™ and Weck™ – trusted brands united by a common sense of purpose At Teleflex, we are empowering the future of healthcare. For more information, please visit teleflex.com. Forward-Looking StatementsAny statements contained in this press release that do not describe historical facts may constitute forward-looking statements Any forward-looking statements contained herein are based on our management's current beliefs and expectations uncertainties and changes in circumstances which may cause actual results or company actions to differ materially from what is expressed or implied by these statements These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission Kandzari is a paid consultant of Teleflex Incorporated or its affiliates Limited by Federal (or United States) law to investigational use and Weck are trademarks or registered trademarks of Teleflex Incorporated or its affiliates in the U.S For Teleflex Incorporated:Lawrence KeuschVice President, Investor Relations and Strategy Developmentinvestor.relations@teleflex.com 610.948.2836 Krystian Budulski In this article we take a look at some of the best IDEs for Flutter development Flutter as a cross platform development kit has been picking up steam for quite some time now but also because of a great support by Google constantly adding new features and allowing developers to catch up with the new trends like Material 3 Developing apps with this framework can be a great experience but to make the most out of it - increase both the quality of the product and your own productivity - you probably should skip the notepad part and move on straight to the more robust solutions This article will compare two of the most popular and widely used integrated development environments for mobile app development - Visual Studio Code and Android Studio analyzing them from many angles and trying to see which one comes ahead Visual Studio Code often referred to as VSCode is a lightweight IDE provided by Microsoft It supports quite a lot of languages and offers plenty of extensions to choose from In its nature it may be even similar to Flutter itself - you start with basic setup choose plugins and packages that you need and you’re ready to go Visual Studio Code excels at being minimalistic It can have all the necessary functionalities and in case something is missing there will most likely be an extension for that The only downside is that there may be a need for a dedicated IDE like Xcode when developing some native parts should the need arise but it is still possible to write code in VSCode with basic support included Android Studio on the other hand is the official IDE for Android development provided by Google It offers way more features out of the box but because of it also comes with a price of being heavier and working slower There is a possibility to install additional extensions as well although not as many as offered in the other IDE Android Studio is a full package IDE being constantly updated and recommended as a go to solution for developing both native and Flutter applications It has all the tools and features a developer needs run configurations and plenty of other things But because of all those features packed right from the start it has higher requirements and development experience may not be as good on slower machines It seems like both Android Studio and VSCode go hand to hand in the case of listed features Key difference is in the performance and native code support experienced developers should not have any problems with using both IDEs along with Xcode which is really useful in case there is a need to configure Flutter from the native side and thanks to a lot of extensions that deliver everything that is needed and even more developing apps with it may be a very good option But keeping Android Studio and Xcode ready on the shelf knowing how to use it and being able to easily switch between all of them fluently is probably the best jack of all trades option one can choose Also there will rarely be a case when in one project all the developers are using only one IDE so adding run configurations for both to version control will surely make the onboarding process a little bit easier and smoother for any new developer joining the project discussed the superior efficacy with ide-cel vs standard care in relapsed/refractory multiple myeloma Targeted Oncology: How was idecabtagene vicleucel (ide-cel; Abecma) evaluated in patients with relapsed/refractory multiple myeloma the key inclusions stated patients had to have at least 2 to 4 previous regimens Some of them had high-risk cytogenetics and some of them didn't.1 These patients were also allowed to cross over if they were confirmed to have progressive disease during that time period as well The investigators were looking at progression-free survival [PFS] Looking at the number of patients on the ide-cel arm vs standard arm a lot of them had already been exposed to IMiDs most of them with lenalidomide [Revlimid] and then pomalidomide [Pomalyst] and then very few with thalidomide [Thalomid] Most people don't use thalidomide nowadays a majority of them received bortezomib [Velcade] and then carfilzomib [Kyprolis] Pretty much all of them received daratumumab at some point There were 24% who had extramedullary disease Who was included in the KarMMa-3 trial in terms of location and race As far as ethnicities and things like that a lot of patients were here in North America and then there were [a small number of] Japanese patients as well I think one thing to look at with these trials is that—especially with showing these data a lot of times to the patients—there weren't a lot of African Americans included in these trials although a significant amount of the population in multiple myeloma are African American That was one discrepancy I found that I wasn't too pleased about when it comes to that… A lot of my African American patients do very well and have a high rate of survivability I haven't seen too many who have had a significant amount of relapsed disease That’s something I would have love to have seen represented in these data What were the efficacy findings for this relapsed/refractory multiple myeloma patient population the median PFS for ide-cel was 13.8 months whereas the standard regimen median PFS was 4.4 months [HR the PFS rate was 41% for those patients receiving ide-cel compared with the standard-of-care arm at 19% There's a significant difference when it comes to PFS.2 The median OS for patients in the ide-cel arm vs the standard arm was 41.4 vs 37.9 months [HR There was not a significant difference when it comes to that 71% of patients had an overall response…compared with the standard arm at 42% ORR.1 With ide-cel 41% of those patients were able to achieve a stringent CR That allows them to stay disease free and helps maintain disease free [status] during that time period as well and then there were 18% with very good partial response This is compared with just 5% with stringent CR with the standard of care there was a better response with the ide-cel arm compared with the standard of care There were 57 patients with MRD-negative CR whereas they weren't getting the significant deep remission rates with the standard of care [at 2%] How did patients on KarMMa-3 do in terms of toxicity with the CAR (chimeric antigen receptor) T-cell therapy Ninety-nine percent of the patients had some sort of adverse event [AE] during the [trial] period with ide-cel; grade 3 or 4 AEs were 93% during that time period as well Patients experienced [high rates of] neutropenia For lymphopenia and leukopenia…patients can have these prolonged cytopenias up to almost 2 months after they receive CAR T-cell therapy so it's another reason why you have to monitor them very closely after they receive ide-cel or other CAR T cells They will experience some nausea and vomiting I think that's more contributing from the lymphodepleting chemotherapy possibly more compared with the CAR T itself But it's hard to decipher because they follow each other very quickly Fatigue is something you expect patients to experience and also fever and headache many times I'll factor in as possibly a sign of immune effector cell-associated neurotoxicity syndrome [ICANS] when they start to develop a headache although a lot of times it'll come along with a tremor and we associate it with some confusion as well we lump in headache and if it is refractory 88% of patients had experienced cytokine release syndrome and then 15% of patients experienced neurotoxic events Grade 3 or 4 cytokine release syndrome [was 4%] Ide-cel or standard regimens in relapsed and refractory multiple myeloma Ide-cel vs standard regimens in triple-class-exposed relapsed and refractory multiple myeloma: updated KarMMa-3 analyses Stay up to date on practice-changing data in community practice FDA Grants ISB 2001 Fast Track Designation in RRMM ISB 2001 has gained fast track designation from the FDA for the treatment of relapsed/refractory multiple myeloma Dhakal Reflects on the FDA Approval of Cilta-Cel for Earlier Lines of RRMM discusses the recent FDA approval of ciltacabtagene autoleucel for the treatment of relapsed/refractory multiple myeloma CRS and ICANS Show Low Severity With Bispecifics in Multiple Myeloma discusses adverse events in the MajesTEC-1 study of teclistamab in multiple myeloma Advancing Myeloma Treatment With Blood-Based MRD Testing dissects the latest advancements in myeloma treatment focusing on the role of ClonoSeq and minimal residual disease monitoring Talquetamab Shows Promise for High-Risk Relapsed/Refractory Myeloma discussed talquetamab’s efficacy in relapsed/refractory multiple myeloma Starting Therapy for Intermediate-Risk Myelofibrosis Based on Hemoglobin and participants discussed selection and timing of initiation of JAK inhibitor therapy for myelofibrosis 609-716-7777 discussed the KarMMa-3 subgroup analyses and quality of life for patients with relapsed/refractory multiple myeloma Targeted Oncology: What was shown in the subgroup analysis of bridging therapy to idecabtagene vicleucel (ide-cel; Abecma) in relapsed/refractory multiple myeloma MD: [The investigators of KarMMa-3 (NCT03651128)] looked at the subgroup analysis of ide-cel after triple-class therapy and the change in disease burden by the bridging therapy received So if patients received daratumumab [Darzalex]/pomalidomide [Pomalyst]/dexamethasone as bridging therapy prior to receiving CAR [chimeric antigen receptor] T-cell therapy Only about 20% of those patients had decreased disease and then [another 20% had] increased disease it seems like most of the patients who responded the best were those who received carfilzomib [Kyprolis] and dexamethasone I think that's also something you can notice; a lot of times with the patients if they are slow responders or have progressive disease I recommend patients being changed over to carfilzomib I have seen that they have a great response to carfilzomib compared with bortezomib [Velcade] But we do use that as more in the second line because it can cause more significant cytopenias.1 Not as many people had decreased disease when it came to daratumumab/bortezomib/dexamethasone which a lot of times is part of our first-line therapy as well So it possibly could be related to patients having been exposed to this in the past With the triplet therapy moving towards quadruplet therapy and daratumumab being part of that new quadruplet a lot of people are being exposed to daratumumab Sometimes they don't necessarily respond as well compared with other regimens that they would not have seen before Progression-free survival in these patients who had a decrease in their disease burden had a better progression-free survival [and] patients who did not have any change in their disease had better PFS compared with patients who had increased disease What were the responses and soluble B-cell maturation antigen (BCMA) by disease burden in the subgroup analysis results Soluble BCMA is measured in the blood [to see] how significant it is Patients who had an increase in their disease typically had a higher amount of soluble BCMA in the blood compared with patients who had no change in the disease or had a decrease in their soluble BCMA Looking at the different percentages of overall response in the arm where there's an increased disease and then the arm with no change in disease and with decreased disease the patients who have decrease in their disease pre-transplant with the bridging therapy were able to achieve a higher rate of stringent CR compared with patients who had an increase in disease That goes to the fact that the higher the disease burden itself the more likely these patients are going to not respond as well and more likely that they're also going to relapse sooner than later That speaks to the fact that the disease would be in these patients [they] probably have higher-risk cytogenetics What were the results for the patients’ quality of life (QOL) in the KarMMA-3 trial Investigators looked at how patients subjectively felt their life changed with ide-cel compared with patients who received standard of care.2 In these patients they checked...254 patients randomly assigned to the ide-cel arm and 132 to the standard regimen.3 The baseline characteristics were balanced across the different treatment arms Both arms had a median age of about 63 years and also a median time of myeloma diagnosis was about 4 years ago Their QOL scores were generally comparable between the treatment arms they're saying that patients had an improvement [with ide-cel].2 Patients are saying that they had an improvement in their fatigue when they received ide-cel compared with standard of care they felt like they had fewer financial difficulties in the ide-cel arm compared with standard of care They felt like their disease symptoms were better in the ide-cel arm subjectively compared with patients who were in the standard-of-care arm as well They also felt like their cognition was improved A lot of times patients will complain about "chemo brain," the brain fog after they receive their therapies they felt like they had better social functioning compared with patients who receive the standard of care This is at month 25; from the beginning of the trial to 25 months afterwards Idecabtagene vicleucel versus standard regimens in triple-class-exposed relapsed and refractory multiple myeloma: KarMMa-3 subgroup analysis in patients receiving bridging therapy Presented at: IMS 20th Annual Meeting and Exposition; September 27-30 Effects of idecabtagene vicleucel (ide-cel) versus standard regimens on health-related quality of life (HRQoL) in patients with relapsed/refractory multiple myeloma (RRMM) who had received 2–4 prior regimens: updated results from the phase 3 KarMMa-3 trial Tampa, Florida – Concept Medical Inc. a global pioneer in innovative drug delivery technology is proud to announce the successful enrolment of the first patient in the “MAGICAL BTK” (Randomized Controlled Trial of MagicTouch PTA – Sirolimus Coated Balloon Versus Standard Balloon Angioplasty in the Treatment of Below The Knee arterial disease) U.S Investigational Device Exemption (IDE) pivotal trial and his team at the Icahn School of Medicine at Mount Sinai marking a crucial milestone in the advancement of treatment options for patients suffering from peripheral artery disease (PAD) below the knee Following the recent IDE Approval by the U.S. Food and Drug Administration (FDA) for MagicTouch PTA, this enrolment heralds the beginning of Concept Medical’s peripheral clinical trial program in the United States. With the ongoing IDE study for MagicTouch SCB in coronary artery disease Concept Medical is now actively enrolling in two U.S clinical trials in both coronary and peripheral interventions—an unprecedented achievement aimed at improving patient outcomes and expanding therapeutic choices      “The enrolment of the first patient in the MAGICAL BTK trial represents an important stride toward improving the standard of care for below-the-knee disease in patients with peripheral artery disease,” said Dr “Sirolimus-coated balloon technology has the potential to significantly enhance limb salvage and patient quality of life I am honored to be part of this landmark study and look forward to the meaningful clinical evidence it will generate.” The MAGICAL BTK pivotal trial is designed to evaluate the safety and effectiveness of MagicTouch PTA Sirolimus Coated Balloon compared to standard percutaneous transluminal angioplasty (PTA) for the treatment of below-the-knee arterial disease ensuring that the trial’s findings focus on meaningful clinical outcomes with a distinguished panel of Principal Investigators including Dr Eric Secemsky (Beth Israel Deaconess Hospital and Harvard Medical School) Brian DeRubertis (NY Presbyterian Weill Cornell Medical Center and Cornell University Medical College)      “The initiation of the MAGICAL BTK Trial heralds a new era in the treatment of patients with chronic limb-threatening ischemia and offers hope to the millions of patients with this condition who are at risk for limb loss because of insufficient arterial circulation in their legs,” stated Prof Sirolimus-coated balloon technology has already reshaped coronary and peripheral artery disease management with MagicTouch achieving positive results in large-scale trials across Asia and Europe. patients have the opportunity to benefit from this breakthrough approach patient enrolment from Asia will broaden the global patient cohort offering a more comprehensive understanding of the therapy’s benefits across diverse populations our unwavering commitment to innovation and patient care drives us to push the boundaries of what is possible in vascular interventions,” said Dr Manish Doshi (Founder & Managing Director) “The start of MAGICAL BTK further validates our dedication to bringing next-generation evidence-based solutions to clinicians and patients worldwide ensuring better outcomes and improved quality of life for those affected by PAD.” With the MAGICAL BTK trial and the MAGICAL SFA IDE trial for superficial femoral artery (SFA) treatment set to begin Concept Medical is poised to revolutionise endovascular care The company’s distinctive technology platform has already elevated the management of coronary artery disease by expanding its reach into peripheral interventions Concept Medical reinforces its leading position in advancing patient-focused has a global presence and is dedicated to enhancing patient care through cutting-edge research and development of drug-delivery technologies Its proprietary platforms are designed to deliver pharmaceutical agents across vascular luminal surfaces with unparalleled precision Concept Medical is the developer of the MagicTouch family of Sirolimus Coated Balloons (SCBs)—the world’s first and most utilized SCB technology—well recognized for its versatility and efficacy in treating coronary and peripheral artery disease The revolutionary MagicTouch and Abluminus product lines have been used to treat over a million patients globally setting a new standard for vascular therapy For more information, please visit www.conceptmedical.com pr@conceptmedical.com Abdulwahid Barguzar Python Integrated Development Environments (IDEs) are the cornerstone of efficient programming offering a rich set of tools in a single application These environments streamline the coding process with features like intelligent code completion and debugging tools Python's interpreter language nature benefits greatly from IDEs which manage code execution and error handling Python IDEs are diverse and cater to various needs from the fully-featured powerhouse that is PyCharm to the simplicity and ease of Python's own IDLE which is particularly suited for beginners developers can enjoy a more organized and productive coding experience with all necessary tools at their fingertips from code linting to version control integration The choice of IDE can significantly impact the speed and quality of software development making it a critical decision for Python coders simple code editors like Sublime Text and Atom offer a lightweight alternative focusing on the essentials of writing Python code with syntax highlighting and code formatting capabilities becoming highly customizable Python development environments with the addition of plugins and packages for scientific development and other specialized needs Whether choosing an all-in-one IDE or a modular code editor developers have a wealth of options to enhance their coding efficiency At the heart of Python programming is the IDE or code editor serving as the primary tool for python development An IDE is more than just a text editor; it integrates various development tools including a code editor with built-in support for Python This creates a seamless environment where writing and deploying Python code can be done with ease and precision are an essential part of the developer's toolkit especially prized for their flexibility and lightweight design Many editors offer built-in support for Python and become highly customizable with plugins for syntax highlighting They are an ideal starting point for those new to Python allowing for an easier transition into more complex programming tasks as proficiency grows Python IDEs are applications which can be used for developers building software with the Python programming language. IDEs are vital tools in software development because they allow developers to start programming new applications quickly as multiple utilities don't need to be manually configured and integrated as part of the setup process This speed can help to lower the cost of overall development for a business and the automation and debugging capabilities lead to cleaner what they are and what they can help you achieve in your software development you’ll be able to identify the best tools to help you build an excellent Python code application and the different use cases for various integrated development environments IDEs serve as the command center for Python developers offering a suite of tools that automate and simplify many aspects of the coding process These environments support Python's dynamic nature with features like expression evaluation and intelligent code completion which accelerate the writing of robust and error-free code which are indispensable for running scripts and interactive coding sessions IDEs become invaluable by providing advanced tools such as integrated debuggers and debugging tools These features allow developers to quickly identify and address issues within their code ensuring the delivery of high-quality software The role of an IDE is to provide an efficient allowing developers to focus on crafting innovative Python solutions Code editors stand out for their simplicity and efficiency when writing Python code making them quick to launch and responsive during use—a boon for developers who value speed code editors can be transformed into full-fledged Python development environments with the addition of plugins and packages Python developers appreciate code editors for their highly customizable nature allowing for a personalized coding experience Features such as code linting enhance code quality by flagging potential errors before runtime code editors provide a flexible and approachable platform for both novice and experienced programmers to craft their Python projects Integrated Development Environments (IDEs) elevate Python coding by offering a holistic suite of tools in one unified package enabling developers to write and test their code in an interactive environment This level of integration reduces the friction and time spent switching between tools IDEs often come with sophisticated debugging tools which are crucial for diagnosing and resolving issues efficiently This comprehensive approach to development makes IDEs an indispensable asset for Python programmers aiming to build reliable and high-performing software Python's popularity has led to the creation of a diverse ecosystem of IDEs each aiming to cater to different aspects of Python development This year's top Python IDEs represent a broad spectrum from those designed for beginners to those tailored for professional developers and specialized fields like data science While there is no one-size-fits-all solution each IDE has its unique strengths that can be matched with the specific needs and requirements of projects and developers Python has been used in development services for almost 30 years and it is one of the most dynamically growing languages today It is also known for being one of the most versatile software development technologies and that is down in part to the great number of IDEs available to use with Python providing a simple and accessible environment for those new to the language offering smart indentation and supports syntax highlighting which are foundational tools for writing clean and readable code IDLE is an ideal starting point for learners to familiarize themselves with Python's syntax and semantics While IDLE may lack the advanced features of full-fledged IDEs allowing beginners to focus on the basics without being overwhelmed by complexity Its straightforward interface and essential coding tools provide a solid foundation for anyone starting their Python programming journey Python IDLE (Integrated Development and Learning Environment) is included in Python installations on Windows and Mac then you should be able to find and download Python IDLE using your package manager you can then use Python IDLE as an interactive interpreter or as a file editor IDLE is written in Python and is ideal for novice developers who want to improve with Python development so you can build simple projects such as web browser games Thonny is a welcoming IDE for beginners embarking on their Python journey Its straightforward and intuitive user interface is designed to minimize distraction and ease the learning curve for those new to programming The simplicity of Thonny makes it an inviting platform for novice developers to start writing Python code and exploring the language's possibilities Thonny's approachable design is complemented by essential features that help beginners understand the basics of Python and development practices Its clear and clean layout aids in building confidence as beginners gradually master Python's syntax and concepts making Thonny a nurturing environment for the programmers of tomorrow Thonny is great because it’s free and simple to use, but also has a number of features which make it useful for full Python development projects. You can see why your code breaks with a built-in debugger assistant that highlights errors and suggests improvements Atom is an open-source code editor known for its modularity and customizability Atom boasts a welcoming interface that can be tailored to individual preferences and workflow requirements Its extensibility through packages and themes makes it a highly customizable coding companion for Python developers Atom's emphasis on usability and community-driven development has resulted in a tool that is both powerful and approachable Its open-source nature invites collaboration and innovation ensuring that Atom remains at the cutting edge of code editing tools For Python programmers seeking a flexible and user-centric editor Atom creates packages that add to its hackable core Atom’s plugins help to streamline the Python development process by extending core functionality and it’s easy for developers to customize aspects of Atom to their own requirement Eric is a full featured Python editor and IDE everyday code editor but can also be used as a professional project management tool providing a full complement of development features and is great for projects such as web applications and scientific research meaning you can extend functionality with downloaded plug-ins from the net and is compatible with many other programming languages making it a highly flexible and versatile tool for Python development The Wing Python IDE family of integrated development environments from Wingware was created specifically for the Python programming language multi-thread programs and supports remote debugging The editor is also versatile and very popular with developers for its high functionality It has VI and emacs mode and is extensible with Python scripts Sublime Text 3 is a popular code editor that supports many languages Sublime Text is a favorite among developers who prioritize performance Its elegant user interface and powerful features combine to create an enjoyable coding experience Highly customizable and extensible through plugins it can be tailored to suit a developer's specific workflow making it a versatile choice for Python programming Its freemium model allows users to evaluate the editor for an indefinite period with the option to purchase a license for continued use Sublime Text is known for its speed, ease of use and strong community support, making it a great tool for beginner developers or those working to tight project deadlines. An additional bonus of using Sublime Text as a Python developer is that plugins are written in Python. Python developers can extend Sublime Text with their own programming language rather than learn a new language PyDev is a third-party plug-in for Eclipse which is an Integrated Development Environment used for programming in Python PyDev is beloved by Python developers because it is free simple to get started with and provides code completion tools and advanced analysis which streamline the development process and make programmers’ lives easier Spyder is an open-source IDE specifically designed for scientific development within the Python ecosystem It integrates seamlessly with data science and machine learning libraries making it an excellent choice for researchers and scientists who require a Python development environment tailored to their needs Spyder comes with a wealth of features for data exploration and analysis including advanced graphical capabilities and a variable explorer combined with its Python interpreters and debugging tools make Spyder an indispensable tool for scientific computing with Python This offers developers advanced visualization capabilities and other development tools as well as strong community support Spyder is an excellent tool for data science PyCharm stands as a top-tier all-encompassing Python IDE widely recognized for its comprehensive set of development tools that cater to all aspects of the python programming language Its robust features include support for web development frameworks like Django and Flask and direct integration with Google App Engine making it an ideal choice for a wide range of Python development projects Designed to be the go-to ide for professional developers PyCharm offers a wealth of functionalities such as advanced code navigation and built-in tools that streamline the development process These features combine to make PyCharm a powerhouse that can handle complex and large-scale Python applications with ease Python helps developers build Python plug-in and provides a customizable user interface which can be adapted depending on the needs of the development project and helps developers write maintainable code keep control of the quality with PEP8 checks and a host of inspections and offers intelligent code completion is a versatile editor that has gained immense popularity among Python developers Its smart code completion and wide array of extensions make it a highly adaptable tool that can accommodate a variety of programming tasks The editor is known for its performance and user-friendly interface appealing to professionals and beginners alike Visual Studio Code provides a rich development experience without the associated cost making it an accessible choice for developers around the world Its versatility and robust feature set make it a go-to editor for Python programming and beyond is revered among veteran programmers for its efficiency and the extensive command-line interface it offers Vim's lean design and keyboard command-centric approach enable programmers to navigate and edit code with remarkable speed Despite its steep learning curve and a reputation for being less intuitive for beginners Vim's highly customizable nature and lightweight architecture make it a compelling option for seasoned developers focused on productivity The versatility of Vim is further underscored by its ubiquity; it comes pre-installed in the terminals of macOS and most Linux distributions While the Windows version might present challenges continues to attract developers who appreciate a tool that grows with their expertise Even as it perpetuates the playful 'Editor war' with Emacs enthusiasts Vim stands firm as a reliable tool for those willing to master its shortcuts and commands A Python coding environment distinguishes itself with a suite of features designed to maximize developer efficiency and code quality a good coding environment should include a capable code editor which is essential for writing and editing code with ease The incorporation of debugging tools is another critical aspect as they play a pivotal role in identifying and rectifying errors ensuring that the code functions as intended In addition to these fundamental components an outstanding Python environment also integrates libraries and Python interpreters offering a comprehensive set of tools to extend the language's functionality and library support creates a cohesive and effective development space that empowers developers to produce robust and reliable Python applications Real-time error checking and auto-completion are features that elevate a Python IDE from good to great These tools provide immediate feedback to developers as they write code highlighting potential issues and suggesting corrections on the fly This not only speeds up the development process but also helps in maintaining a cleaner codebase by catching errors early is a boon for developers as it reduces keystrokes and minimizes the risk of typos By predicting the programmer's intentions and offering relevant suggestions these features enhance the overall coding experience Debugging capabilities and code navigation are indispensable for a productive Python development experience Robust debugging tools enable developers to step through code which is crucial for diagnosing and fixing bugs These tools often come integrated with IDEs or can be added to code editors via plugins providing a seamless debugging environment simplifies the process of moving through complex codebases Features such as "go to definition" and "find references" help developers quickly locate and understand code segments thereby enhancing their ability to manage and maintain large projects efficiently Integration with version control systems is a feature that modern Python IDEs and code editors cannot overlook Version control is a cornerstone of professional software development providing a safety net for code changes and facilitating collaboration among team members An IDE with built-in version control support streamlines the development workflow and manage branches directly within their coding environment This integration brings a level of convenience and efficiency that is highly valued in fast-paced development settings By enabling developers to handle version control tasks without leaving their IDE it reinforces the importance of maintaining a well-organized codebase and encourages best practices in code management Selecting the ideal Python IDE hinges on understanding your development needs and matching them with the right set of features the Python programming language is versatile and different projects may require unique tools and functionalities An IDE that excels in web development may offer integrated support for frameworks like Django or Flask while another might be optimized for data analysis with tools for scientific computing the decision can also be influenced by personal preferences and working styles Some developers may prioritize a user-friendly interface and ease of setup while others might seek extensive customization options it's crucial to evaluate the IDEs available and choose one that not only aligns with the technical requirements of your project but also complements your approach to development one's expertise level plays a crucial role in determining the most suitable environment Novice programmers may gravitate towards IDEs that offer a gentle learning curve and straightforward functionality provide the essential tools without overwhelming new users with complexity allowing learners to focus on mastering the basics of Python experienced developers often seek more sophisticated IDEs that offer a plethora of features and customization options Advanced IDEs like PyCharm and Visual Studio Code cater to these demands with their extensive toolsets including powerful refactoring capabilities and a wide array of plugins and extensions These environments facilitate the management of large-scale projects and cater to the nuanced needs of seasoned professionals When selecting a Python Integrated Development Environment (IDE) or code editor it's essential to align the choice with the specific needs and objectives of the project at hand are indispensable for complex software development as they help identify and resolve issues efficiently For projects that rely heavily on particular libraries an IDE that seamlessly integrates with these and facilitates their management can significantly enhance productivity the complexity of the project should guide whether a simple code editor suffices or if a more comprehensive IDE is required larger projects might benefit from an IDE with advanced features like integrated version control which streamlines collaboration and code management ensuring consistency and reliability in development workflows For beginners eager to delve into Python programming without the hassle of installing Python or configuring a local environment Programiz offers an accessible online compiler This tool allows for immediate coding in a web browser requiring nothing more than an internet connection The simplicity of this setup makes it an excellent choice for those new to programming who wish to focus on learning the language rather than navigating the complexities of installation and environment setup The Programiz online compiler is not only user-friendly but also completely free removing barriers to entry for aspiring programmers beginners can concentrate on developing their skills and understanding of the language setting a strong foundation for future development endeavors With so many options to help enhance your Python application development but these IDEs also help experienced developers and programmers streamline their processes when writing code and maintaining software With features ranging from syntax highlighting, code editors, smart code navigation and smart code completion to data science functionality and integrated debugger tools these IDEs contain essential tools to optimize your Python development and ensure you release the best possible application to your customers Whether you’re starting with IDLE or taking advantage of the full features of PyCharm it can be difficult to know which IDE suits the needs of your specific project If you’re still unsure after reading this article We have a team of expert Python developers who are happy to help with any project requirements The landscape of Python IDEs and code editors is poised for evolution driven by the growing demands of software development Integrated development environments are expected to further streamline project management and enhance features like syntax highlighting and auto-completion making coding in Python even more efficient The future will likely see more sophisticated AI-driven code editing providing smarter code inspections and code refactoring tools that adapt to the coder's style and project needs and other systems will increasingly integrate with tools like git for seamless version control and support test-driven development more robustly The trend towards remote development will enhance IDE capabilities allowing for remote debugging and virtual environment management Python IDEs will continue to integrate scientific python development catering to a wide array of Python projects and developers' diverse requirements Company marks 500th patient enrolled in the study and gains significant clinical experience with its next-generation CLAAS® AcuFORM™ Left Atrial Appendage Device NASHUA, N.H., April 2, 2025 /PRNewswire/ -- Conformal Medical, Inc. a medical device company specializing in stroke prevention technology announces the enrollment of its 500th patient in the company's CONFORM IDE Trial randomized controlled study is evaluating the safety and efficacy of the Conformal CLAAS AcuFORM System compared to other commercially available left atrial appendage (LAA) devices and aims to enroll approximately 1,600 patients reaching close to a third of the intended enrollment and is a major step forward in validating the CLAAS System for patients with non-valvular atrial fibrillation (NVAF) "I am pleased with the performance of the next-gen CLAAS AcuFORM System." Professor of Medicine and Director of the Atrial Fibrillation and LAA Closure Programs at Vanderbilt Health Nashville Assistant Professor in Interventional Cardiology at West Virginia University Bernards Medical Center and White River Medical Center and Director/CEO Arrhythmia Research Group were among the first operators to implant the next-generation CLAAS AcuFORM left atrial appendage occlusion (LAAO) device The CLAAS System aims to provide patients and physicians with an alternative option to seal the LAA with only two sizes to reduce stroke risk without needing long-term anticoagulant therapy "I am pleased with the performance of the next-gen CLAAS AcuFORM System Enhancements to the delivery system and the implant combined with the addition of a steerable sheath have improved the performance and ease of use," said Dr "I believe this system has the potential to be a meaningful advancement and I look forward to validating this as we continue enrollment for the CONFORM Trial." Conformal confirms that the next-generation CLAAS AcuFORM device has been implanted in 51 patients worldwide garnering enthusiastic support from the physician community across the globe and underscoring the potential of the technology to benefit patients and physicians The device is designed to naturally conform to the LAA instead of reshaping it as seen with commercially available devices The CLAAS AcuFORM implant features a self-expanding nitinol endoskeleton for flexibility and an adaptive foam matrix that is intended to fill gaps for a better seal reducing complications and providing a more patient-friendly solution "Reaching the 500th patient enrollment in the CONFORM IDE Trial is a testament to the dedication of the Conformal team and the trust our implanting physicians place in our technology," commented James Reinstein "We are committed to advancing stroke prevention technology and look forward to delivering the CLAAS AcuFORM System to market in the coming years." About Left Atrial Appendage ClosureMore than six million people in the United States suffer from Afib placing them at an increased risk of stroke.1 Current standard of care for stroke prevention is chronic oral anticoagulants which are not well accepted by patients due to concern about associated risk of bleeding Left Atrial Appendage Occlusion (LAAO) is emerging as an important alternative to blood thinners for preventing strokes in patients with non-valvular Afib First-generation LAAO devices are an estimated $1.4B global market in 2023 and are expected to grow to over $6B by 2030.2,3 The CLAAS System is limited by Federal (or United States) law to investigational use Epidemiology of Atrial Fibrillation in the 21st Century: Novel Methods and New Insights today announced that the early results of its GLACE Study will be presented during the Annual AF Symposium in Boston the next-generation CLAAS® AcuFORM™ Left Atrial Appendage Occlusion (LAAO) System will be highlighted during .. prospective study will evaluate EndoQuest’s state-of-the-art Endoluminal Surgical (ELS) System’s safety and performance in robotic endoscopic submucosal dissection (ESD) procedures for the removal of colorectal lesions Fifty subjects will participate across five leading US healthcare institutions including Brigham and Women’s Hospital (Boston) “This IDE approval marks a significant milestone in EndoQuest’s mission to revolutionize minimally invasive surgery,” said Eduardo Fonseca “Our flexible robotic technology has the potential to transform colorectal surgical outcomes empowering physicians with innovative tools to deliver less invasive We’re excited to proceed to human cases and move one step closer to initiating the next paradigm of surgery.” “We’re thrilled to have received approval from the FDA to start our clinical trial,” said Dr chief medical officer and chairman of the scientific advisory board of EndoQuest Robotics “This technology represents the evolution we have been waiting for to finally perform endoluminal surgery which could redefine what’s possible in minimally invasive colorectal procedures and potentially allow a significant number of patients to avoid invasive operations like colectomies.” EndoQuest’s Flexible Robotic System is under development and is not yet available for commercial sale in the United States For media inquiries or further information about EndoQuest Robotics and its groundbreaking advancements in flexible endoluminal robotics Media ContactLisa OwensThe Mullings Grouplowens@mullingsgroup.com+1-210-601-6647 cross-platform mobile and desktop apps with .NET MAUI This IDE features hot reload capabilities across .NET and C++ apps and developers can use IntelliCode for efficient coding by typing less and coding more It provides deep insights into code with features like CodeLens revealing information such as recent changes Edit and debug collaboratively with Live Share's real-time collaboration sessions Hardware requirements include at least 4GB RAM with a recommendation of 16GB along with up to 210GB disk space and a Quad-core or better processor This license can be used on one desktop or mobile device and lasts for life For a limited time, get Microsoft Visual Studio Pro 2022 for Windows for A$43 StackSocial prices subject to change Lifehacker has been a go-to source of tech help and life advice since 2005 Our mission is to offer reliable tech help and credible science-based life advice to help you live better Lifehacker is a federally registered trademark of Ziff Davis and may not be used by third parties without explicit permission The display of third-party trademarks and trade names on this site does not necessarily indicate any affiliation or the endorsement of Lifehacker If you click an affiliate link and buy a product or service MassDevice The Medical Device Business Journal — Medical Device News & Articles | MassDevice March 24, 2025 By IDE enables the company to evaluate the system in treating severe calcification in coronary arteries prior to stenting The company expects its TECTONIC coronary artery disease (CAD) IVL trial to enroll up to 335 subjects at 47 U.S The current approaches for clearing calcified arterial blockages include cutting balloons and atherectomy technology fractures the calcium within the artery wall This potentially allows for vessel expansion and better stent placement Abbott’s investigational system utilizes high-energy sound pressure waves to treat calcium blockages prior to placing a stent to achieve this Abbott said its investigational IVL technology builds upon its existing vascular portfolio It aims to address the challenges of currently available IVL systems “Abbott is a leader in treating coronary artery disease offering the best diagnostics and therapeutic options for calcium detection and treatment at every stage Through our expansive portfolio of treatment offerings we aim to make interventions safer and more effective for people who need them most,” said Jennifer Jones-McMeans divisional VP of global clinical affairs at Abbott’s Vascular business by working with physicians to evaluate Abbott’s coronary IVL system we are exploring the next generation of calcium modification technology advancing our portfolio of treatments for coronary artery disease.” Medical Design & Outsourcing: How Shockwave’s Javelin IVL catheter breaks up blood-blocking calcium where balloons can’t reach Privacy Policy Learn how to describe the purpose of the image (opens in a new tab) Leave empty if the image is purely decorative We're working on a visual shortcode editor until then please follow these instructions Email us to support@plugin.builders for any problems Today marks an exciting milestone for Eclipse developers everywhere: we’re thrilled to announce the public preview of Amazon Q Developer in the Eclipse IDE This integration brings the power of AI-driven development directly into one of the most popular development environments we’ll explore some of its game-changing features and show you how this fusion of traditional IDE and cutting-edge AI can supercharge your development tasks across the software development lifecycle I can’t help but feel a wave of nostalgia mixed with excitement This is one of the most requested IDEs for Amazon Q Developer and I can see why Eclipse was where I cut my teeth in Java programming waiting for what felt like an eternity as it installed both intimidated and thrilled by the possibilities it presented Eclipse has been a stalwart in the world of software development for over two decades now It’s been there through the evolution of Java from the early days of J2SE to the modern Java Platform it’s been more than just an IDE – it’s been a trusty companion on our coding journeys The landscape of software development is evolving at a rapid pace and at the heart of this revolution is Generative AI We’re witnessing a paradigm shift in how we approach coding I’m thrilled to announce a game-changing integration that brings together the familiar comfort of Eclipse with the cutting-edge capabilities of Amazon Q Developer Amazon Q Developer is the most capable AI-powered assistant for software development that reimagines the experience across the entire software development lifecycle By bringing this powerhouse directly into Eclipse we’re not just adding a feature – we’re opening up a new world of possibilities for Java developers Whether you’re a seasoned Java veteran or just starting your development journey Amazon Q Developer in Eclipse is set to become your indispensable generative AI-assistant that accelerates tasks across the software development lifecycle Eclipse developers will be able to chat with Amazon Q Developer about their project and code faster with inline code suggestions By leveraging Amazon Q Developer customizations they’ll be able to receive tailored responses that conform to their team’s internal tools and services helping developers build faster while enhancing productivity across the entire software development lifecycle Let’s take a look at some of the features that will be available to you during public preview Inline code suggestions is an excellent starting point for experiencing Amazon Q Developer AI-powered capabilities and naming conventions to provide context-aware suggestions that the more comprehensive and well-organized your code documentation is the more accurate and helpful Amazon Q Developer’s suggestions will be The Amazon Q Developer chat interface serves as a versatile tool for various development needs or seek guidance on implementing specific functionalities you could ask for sample code to calculate a Fast Fourier Transform in Java or seek assistance in enhancing a database class with additional fields using UUID You can also seamlessly integrate code snippets into your chat interactions with Amazon Q Developer By selecting a code fragment and sending it to the chat window (by right-clicking in the editor and selecting Amazon Q > Send To Prompt) you can ask specific questions about the code or request modifications enabling a more interactive and context-aware coding experience You can also use the right-click menu to ask Amazon Q Developer to explain With customizations, Amazon Q Developer can assist with software development in ways that conform to your team’s internal libraries, proprietary algorithmic techniques, and enterprise code style. Customizations must first be configured by an administrator; they can then be selected in the IDE using the menu in the Amazon Q Developer panel. For more information, please refer to the user guide The Amazon Q Developer plugin for Eclipse IDE preview represents a significant step forward in enhancing the development experience within this trusted platform By integrating AI-powered tools such as inline suggestions and chat Amazon Q Developer empowers developers to work more efficiently across different programming tasks Amazon Q Developer streamlines your workflow allowing you to focus on what matters most — writing great code To get started, install the Amazon Q Developer plugin into your Eclipse IDE The world’s leading publication for data science As developers, we’re constantly searching for tools to enhance our productivity and make coding more enjoyable. I have been using Visual Studio Code (VSCode) for over six years it has been the go-to integrated development environment (IDE) for almost all the developers I have worked with In 2023, Cursor (designed by the Anysphere research lab) raised $8M from OpenAI and $11M in total funding as they delivered the message: we’d like to build a code editor that is more helpful In 2024, many developers began testing or fully transitioning to using Cursor as their primary IDE of choice The purpose of this article is to give you a first-person perspective on my experience using Cursor and how I compare it to VSCode I will be discussing how each IDE performs for Data Science when using their respective AI assistance capabilities Originally forked from Microsoft’s VSCode GitHub repository, the Anysphere team took advantage of its open-source codebase and decided it would be a great foundation for developing Cursor Cursor represents a bridge between current development practices and the future of collaborative human-AI programming Cursor’s mission is to develop an IDE heavily integrated with artificial intelligence (AI) capable of being an order of magnitude more effective than any one programmer By preserving VSCode’s familiar interface and comprehensive extension ecosystem Cursor lowers developers’ adoption barriers making the transition to an AI-powered IDE feel like a natural seamless upgrade rather than a disruptive technological change I have been using VSCode for over 6 years and was a beta tester for GitHub Copilot which I have been paying for since its release but even its default layout provides you with everything you need when working on a project (I can understand why Anysphere kept it this way) VSCode also has a great extension ecosystem Anysphere acknowledged this and decided to keep this as is when developing Cursor On October 29th 2024, Claude 3.5 Sonnet was made available on GitHub Copilot your only LLM option was OpenAI models due to the partnership between OpenAI and Microsoft but seeing alternative LLMs perform better on coding-related benchmarks made it frustrating as they were not available on GitHub Copilot most of my exploratory work is completed using Jupyter Notebooks I found VSCode (and GitHub Copilot) to work really well with Jupyter Notebooks each time a new cell is created you have the option to prompt GitHub Copilot for assistance VSCode also enables you to chat with GitHub Copilot about your project you can prompt GitHub Copilot to assist at a vscode you can prompt GitHub Copilot to look specifically at your code selection All of these shortcuts make using GitHub Copilot with Jupyter Notebooks (and alternative file types) in VSCode really good The introduction of non-OpenAI LLMs is a great addition although still in its infancy I am highlighting high-level points from my experience with VSCode and GitHub Copilot Feel free to message me via social media if you have more specific questions you would like to ask Judging by "My Previous VSCode Experience" one might ask why I decided to download Cursor as my VSCode experience does not sound too bad The primary reasoning for this was due to the growing number of developer advocates I was speaking to who had made the switch themselves. Also around this time, Aman Sanger, Arvid Lunnemark, Michael Truell, and Sualeh Asif appeared on the Lex Fridman Podcast to discuss Cursor in detail I listened for the entire 2 hours and 29 minutes and liked what I heard Cursor is free to install and comes with a free tier that allows you to get a feel for what it is capable of I had to explore Cursor for myself after probably pushing it to one side for far too long My first impression of Cursor was that I was extremely glad they kept the VSCode interface whilst also prompting you to download all of your VSCode extensions straight away Before writing any code (or prompting an LLM) you are presented with a welcome checklist that appears above the explore sidebar The purpose of the checklist is to introduce you to some of Cursor’s primary features this was a nice touch as it introduced you to the shortcuts needed to perform each task using the IDE etc.) I decided to import a side project I had been working on recently It was at this point I realised Cursor does not work as well with Jupyter Notebooks as VSCode there is no "Generate" tab available in Cursor You can still use Ctrl/⌘ + K to prompt an LLM but the experience is not as good as VSCode you can use Ctrl/⌘ + L to chat with an LLM when using Jupyter Notebooks in Cursor the apply feature does not work when accepting LLM-recommended code snippets At this point, I decided to create a new Python project I used .py files only and picked a topic that I had limited experience in and would likely take me several hours to develop an MVP without using AI assistance I decided to select a game development project created using pygame Cursor has a feature called "Composer" which allows developers to generate an entire project structure by simply describing their project concept in a prompt developers can leverage AI to streamline the initial project setup you can specify key project information such as: I wanted to test this feature by applying it to my pygame project idea and add all the instructions in a README.md to get the game running and create all the python scripts following the project structure and a very well-documented README.md file was generated explaining to the user how to initiate a game of Tetris All of this was achieved within minutes with some additional time taken to fix minor bugs and redesign the layout of the Tetris board For more information on the features Cursor offers, see here I have decided to use it for all of my future projects The experience I had using Cursor’s Composer feature was incomparable to anything else I have experienced in my professional career as a Data Scientist I see this as a game changer and wouldn’t be surprised if there is a team at Microsoft working on their own version to add to GitHub Copilots offerings With that said, I am not completely turning my back on Vscode there have been some updates to GitHub Copilot showcasing an intent to keep up with competition moving back and forth between IDEs will not require any additional changes to your codebase or IDE configuration My decision between which tool to use will be heavily decided by what features they offer how those features help me with the task at hand GitHub Copilot currently costs 10 dollars per month half the price of Cursor′s Pro tier which costs 20 dollars per month Each offering does not require an agreed contractual period you could alternate month-by-month between the two tools at no extra cost to yourself Disclaimer: All opinions shared in this article are my own based on my personal experience all images included in this article are owned by the author If you enjoyed reading this article, please follow me on Medium, X, and GitHub for similar content relating to Data Science Derivation and practical examples of this powerful concept Symbolic Engines and Unexpected Results - A Personal Coding Experience How to build penalized quantile regression models (with code!) This is a bit different from what the books say I will guide you through the process of analyzing Chess Grandmasters’ openings… Use density-based clustering and survival analysis to estimate when earthquakes occur The world’s leading publication for data science Developers and IDEs go hand in hand developing a project (especially a larger one) would be considerably more challenging than it already is it’s an integrated developer environment For those in the back, an IDE is an application that typically includes the tools that make software development considerably easier. Within an IDE, you’ll find tools like a source code editor, automation tools and features for debugging an IDE gives you everything you need to build an application other than the necessary skills required to write the code some IDEs can give you a leg up with that (thanks to libraries If you’re a fan of open source you might be interested in knowing that there are IDEs available under a license that will appease your need to be productive while also being open But what are those open source IDEs of which I speak keyboard shortcuts and a large repository of extensions to expand the feature set you can also configure frameworks for testing within the language you are using the debugging feature in VS Code makes debugging your code very efficient Without a doubt, the best features found in VS Code are its customizability and IntelliSense code completion the application will present a context menu with related options that can help save you time VS Code is an outstanding option for just about any language VS Code is available for free and can be viewed on GitHub VSCodium is the community-driven port of Microsoft’s VS Code The reason this IDE exists is because VS Code is released under the MIT license but the editor itself is licensed under a non-FLOSS license VS Code contains telemetry and tracking elements VSCodium includes a feature similar to VS Code so you don’t have to worry that you’ll miss out on what you need to work efficiently and effectively macOS and Windows with binary installers for each VSCodium looks and behaves very much like VS Code VSCodium can be installed and used for free Anyone who’s been developing Java applications for any length of time will tell you that Eclipse is the single best IDE for the language To really get Eclipse working as a solid IDE you’ll need to comb through the plugins to find everything you need because Eclipse does have a fairly steep learning curve and the documentation is seriously lacking so you’ll want to have a fairly powerful machine especially if your projects tend to be larger in scope Eclipse is an outstanding option for those who develop within the world of Java Eclipse has one of the steepest learning curves of any IDE on the market For those who want to install Eclipse on Linux You can even get IntelliJ IDEA to work with Python there’s always the terminal window and all the build tools you need available for Linux a leading global provider of water treatment solutions today announced the appointment of Rosemary Niechcial as Chief Executive Officer of the company’s new North America subsidiary who officially joined the company on January 1 will oversee and drive momentum behind all water treatment activities among industrial and municipal customers in the region “I am incredibly passionate about the innovative work the water industry does to secure earth’s most precious resource and ensure people everywhere have access to clean high-quality water,” said Rosemary Niechcial “IDE is an unmatched leader in the industry and the right home for me as I embark on a new career journey I am thrilled to join this team and be part of the organization’s success in solving water challenges for our customers in North America.” Having spent more than two decades in the water treatment industry Niechcial brings extensive experience in key IDE sectors – mining energy – and deep knowledge on critical water infrastructure and navigating successful Public Private Partnerships She has a proven reputation for successfully establishing key partnerships and developing teams and businesses in the Americas Niechcial held senior roles at Baker Hughes Black & Veatch and Veolia Water Solutions & Technologies she will also be tasked with enhancing solutions to suit new PFAS regulations and sustainability efforts “As IDE operations expand to meet water treatment challenges across the globe we aim to increase momentum in North America and need a seasoned professional to lead the organization,” said Alon Tavor “I have full confidence in Rosemary’s experience and excitement for the role she is well-equipped to grow success for IDE in this ever-important market We proudly welcome her to our team and look forward to working alongside her.” To learn more about IDE’s comprehensive water solutions sustainable desalination and large-scale infrastructure projects A world leader provider of desalination and water treatment solutions and operation of some of the world's largest and most advanced thermal and membrane desalination facilities and industrial water treatment plants IDE partners with a wide range of customers 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd the developer of the innovative alpha-radiation cancer therapy Alpha DaRT® Food and Drug Administration (FDA) of an Investigational Device Exemption (IDE) supplement to the IDE previously announced on Jan 27 which had approved a clinical study examining the combination of Alpha DaRT and first-line chemotherapy in 12 patients with newly diagnosed metastatic pancreatic cancer allowing expansion of the clinical trial to a broader group of pancreatic cancer patients The IDE supplement allows the Company to include an additional cohort for locally advanced pancreatic cancer patients and to increase the number of each cohort to 15 patients for a total of 30 patients across the two cohorts “Following the incredible data that we released last week analyzing disease control and overall survival in pancreatic cancer patients treated with Alpha DaRT we welcome the news of this IDE supplement as we continue to move forward in our efforts to explore a new treatment for patients with this deadly disease as quickly as possible.” Alpha Tau is an Israeli oncology therapeutics company that focuses on research and potential commercialization of the Alpha DaRT® for the treatment of solid tumors The technology was initially developed by Prof Alpha DaRT® (Diffusing Alpha-emitters Radiation Therapy) is designed to enable highly potent and conformal alpha-irradiation of solid tumors by intratumoral delivery of radium-224 impregnated sources its short-lived daughters are released from the sources and disperse while emitting high-energy alpha particles with the goal of destroying the tumor Since the alpha-emitting atoms diffuse only a short distance Alpha DaRT® aims to mainly affect the tumor This press release includes "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 words including "anticipate," "being," "will," "plan," "may," "continue," and similar expressions are intended to identify forward-looking statements any statements or information that refer to expectations performance or other characterizations of future events or circumstances All forward-looking statements are based upon Alpha Tau's current expectations and various assumptions Alpha Tau believes there is a reasonable basis for its expectations and beliefs Alpha Tau may not realize its expectations Actual results could differ materially from those described or implied by such forward-looking statements as a result of various important factors and other filings that Alpha Tau may make with the United States Securities and Exchange Commission These and other important factors could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release Any such forward-looking statements represent management's estimates as of the date of this press release While Alpha Tau may elect to update such forward-looking statements at some point in the future even if subsequent events cause its views to change These forward-looking statements should not be relied upon as representing Alpha Tau's views as of any date subsequent to the date of this press release Investor Relations Contact:IR@alphatau.com 2025 (GLOBE NEWSWIRE) -- Lungpacer Medical a leading neurostimulation company committed to advancing therapies that assist patients in overcoming the negative effects of mechanical ventilation (MV) is excited to announce approval of an Investigational Device Exemption (IDE) from the U.S Food and Drug Administration (FDA) for the STARI (STimulation to Activate RespIration) clinical trial This trial will evaluate the feasibility of the company’s investigational AeroNova® System in patients suffering from moderate to severe Acute Hypoxemic Respiratory Failure (AHRF) minimally invasive medical device designed to deliver continuous diaphragm neurostimulation in tandem with mechanical ventilation The investigational device aims to mitigate the harmful effects of positive-pressure mechanical ventilation and reduce the risk of multi-organ ventilator-induced injury This approach has the potential to minimize ventilator-associated injuries across multiple organ systems will explore the potential of transvenous diaphragm neurostimulation-assisted ventilation (DNAV) in mechanically ventilated patients with moderate-to-severe AHRF the AeroNova System will provide bilateral diaphragm activity that allows reduced positive pressure from the ventilator while maintaining patient respiration “This is an important step in advancing our AeroNova System which represents a new frontier in ventilator therapy," said Doug Evans “The STARI trial will provide critical insights into how diaphragm neurostimulation can benefit patients with AHRF and may ultimately reshape the way we treat patients requiring mechanical ventilation.” along with its FDA-approved AeroPace System has the potential to change the landscape of mechanical ventilation treatment offering significant benefits to the nearly 2.5 million U.S patients who are mechanically ventilated each year These therapies aim to decrease ventilator-associated injury and ultimately improve the weaning process for patients recovering from respiratory failure injury or insult to the lung resulting from a national health security threat can lead to AHRF or more severe outcomes and solutions to support diaphragm stimulation may help patients recover from mechanical ventilation The study is being funded in part with federal funds from the U.S Department of Health and Human Services; Administration for Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority (BARDA) AeroPace and AeroNova Lungpacer Medical is dedicated to developing minimally invasive technologies designed to reduce ventilator-induced injury and help patients wean off mechanical ventilation and breathe on their own Lungpacer’s AeroPace® System is used to stimulate the nerves that activate and exercise the diaphragm twice daily to strengthen the diaphragm and facilitate weaning from MV The AeroPace System received premarket approval (PMA) from the U.S Food and Drug Administration (FDA) in December 2024 to improve weaning success – increase weaning and reduce reintubation - in patients ages 18 years or older on mechanical ventilation ≥ 96 hours and who have not weaned utilizes continual diaphragm stimulation in synchrony with mechanical ventilation and is designed to mitigate multi-organ ventilator-induced injury to patients on mechanical ventilation AeroPace and AeroNova have the potential to help the nearly 2.5 million US patients who require mechanical ventilation every year accounting for up to $96 billion annually in direct care costs The AeroPace System is approved by the United States Food and Drug Administration to improve weaning success – increase weaning and reduce reintubation - in patients ages 18 years or older on MV at least 96 hours and who have not weaned The AeroPace System is not approved in any other country CAUTION: The AeroNova System is limited by Federal law (United States) to investigational use Used exclusively for clinical investigations The semiconductor industry is the backbone of innovation today, producing chips and processors that power the digital world. With modern technology evolving at a never-seen-before pace, this industry is exploding — and quickly. In fact, recent data shows the global semiconductor market is projected to grow more than 200% by 2032 from $681.05 billion to $2062.59 billion.  While there is immense opportunity for this industry there are also unique challenges that must be addressed Water Technology connected with IDE Technologies’ director of water treatment process to dig into the nuances of the semiconductor industry from a water-specific lens: A: Chips and processors are hyper-sensitive components requiring ultra-clean water throughout the entirety of the production journey Overlooking water quality can create a plethora of issues — from defects and compromised functionality to an immense decline in product reliability the semiconductor industry must have access to pure water for projects to run smoothly just one of the many water challenges the industry faces today.  A: While the semiconductor industry requires ultra-clean water it does not return the water as it found it the manufacturing process produces contaminated water and in the spirit of protecting the environment and overall public health regulatory bodies have stringent standards around releasing this industrial wastewater discharge into the environment without proper treatment Should the semiconductor industry turn their heads to these rules they could be face-to-face with substantial fines and even legal consequences — but the challenges don’t stop here.  The semiconductor industry also has diminishing access to external water resources given regulators prioritize individual consumers over profitable businesses the pure water required comes at a hefty cost cutting into organizations’ bottom lines sustainable approach to semiconductor manufacturing are turning to water treatment technology A: The semiconductor industry's water treatment is generally divided into three main water treatment sections (besides the secondary users such as cooling towers and scrubbers) The three sections are the ultra-pure water (UPW) the special treatments and the end of pipe Each system has its own special attributes the UPW utilizes technologies such as ultra filtration (UF) degasser and others to ensure the highest purity water is produced to allow safe chips manufacturing.  The special treatments section is actually a collection of all the wastewater from the entire plant after the UPW was used with the addition of chemicals There are various waste streams from various processes during manufacturing such as the CMP process water the hydrofluoric acid treatment wastewater and others It is worth mentioning that each semiconductor fab has its own unique attributes so processes will change from fab to fab and so will the wastewater.  The process to treat the water will vary according to the type of waste and can include technologies like clarifiers But a big portion of it is RO to allow significant water reclaim within the fab as the RO generates high quality products the industry is constantly looking for technologies that will allow it to recycle more water given the challenging wastewater quality IDE has worked to refine the conventional processes introducing a disruptive industrial water treatment solution This technology is called pulse-flow reverse osmosis (PFRO) and enables significantly higher water recovery rates compared to conventional reverse osmosis systems — without the complexity issues and with minimal downtime The third area is the end of pipe (EOP) which is actually the wastewater that is collected at the end of all of the upstream processes (the special treatments section) or directly from the process units to one neutralization basin This water might still need treatment such as peroxide removal ammonia treatment or organic matter removal The common process is the membrane bio-reactor (MBR) to treat the water biologically followed by UF filtration.  because of regulation and public concern such as the rise of per- and polyfluoroalkyl substances (PFAS) regulations and because of the need for more water reclaim — extra water recovery systems can be applied even up to zero liquid discharge systems (ZLD) The main task of the RO is to reach as high as possible water recovery so the expensive crystallizer at the tail will be as small as possible Some plants take the direction of treating the MBR effluent with the high pH process including lime softening and ion exchange for the removal of hardness degasification for the removal of alkalinity and pH adjustment to keep the silica soluble this process calls for substantial effort and is prone to malfunctions and is riddled with chemical use introducing another disruptive industrial water treatment solution This technology is called MAX H2O Desalter and enables high water recovery rates at a neutral pH — without the complexity issues and the chemical demand associated with traditional methods which can notoriously scale the crystallizer heat transfer tube and make it difficult to achieve high recovery rates through treatment This technology is reshaping industrial water treatment as we know it — and the innovation continues there are many options for water treatment technology on the market today allowing the semiconductor industry to get the pure water it needs to stay innovative and successful the semiconductor industry's water management evolution will be primarily driven by the imperative of water reclamation wastewater regulations become more stringent and chip manufacturers pursue ambitious sustainability goals the focus will shift towards maximizing water reuse This will necessitate significant advancements in water treatment technologies particularly in higher water recovery RO systems.  fabs have mainly used reclaimed water for secondary purposes such as cooling tower makeup and scrubbers the primary consumer of clean water is the UPW system and fabs have been reluctant to reuse reclaimed wastewater for UPW production due to associated risks It is clear that with increasing reclamation efforts the reuse of reclaimed water for UPW production will become a significant factor in the years to come and the industry will inevitably move in this direction.